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Synchronous contraction and relaxation of the myocardium is required to 
optimize cardiac function. Regional timing of contraction and relaxation is 
dyssynchronous in many patients with heart failure. Cardiac resynchronization therapy 
(CRT) is a highly successful treatment for dyssynchronous heart failure. Patients are 
currently selected for CRT using surface electrocardiogram QRS duration as a measure of 
dyssynchrony. However, up to 30% of patients selected for CRT show no improvement. 
This poor response rate may in part be explained by the poor correlation between 
mechanical dyssynchrony and QRS duration. Thus, better methods to quantify 
mechanical dyssynchrony in the heart may improve the poor CRT response rate. 
The overall goal of this project was to develop better methods to diagnose 
dyssynchrony in the left ventricle (LV). We developed two new methods with different 
approaches. The first method improved upon existing tissue-Doppler based 
echocardiographic diagnosis of dyssynchrony by utilizing a cross-correlation (XC) 
function to quantify dyssynchrony during post-processing as opposed to the 
quantitatively simplistic “time-to-peak” analysis that is currently utilized. The second 
method utilized standard cine cardiac magnetic resonance (CMR) images to quantify the 
dyssynchrony in the flow of blood within the LV, which may represent a more direct, 
physiologically relevant measure of dyssynchrony.  
Specific aim 1 demonstrated that the new XC delay parameters can be quantified 
accurately with a stationary region of interest and therefore require significantly less post-
 xviii
 xix
processing time to calculate compared to the time-to-peak dyssynchrony parameters. 
Specific aim 2 showed that XC delays are superior to existing time-to-peak dyssynchrony 
parameters at discriminating patients with LV dyssynchrony from those with normal 
function. The time-to-peak parameters showed dyssynchrony in approximately half of the 
normal, healthy volunteers while the XC delay parameters had nearly perfect diagnostic 
accuracy. The results of specific aim 3 showed that XC delays could diagnose acute, 
pacing-induced dyssynchrony in young, healthy children with 79% accuracy while the 
time-to-peak parameters showed accuracies of 71%, 57% and 57%. Specific aim 4 
showed that CMR-based quantification of LV internal flow can be used to discriminate 
patients with dyssynchronous heart failure from normal controls with 95% accuracy.  
In summary, both tissue Doppler-based cross-correlation delay and cardiac 
magnetic resonance-based internal flow analysis may help improve the poor CRT 
response rate by improving the accuracy to diagnose left ventricular dyssynchrony. In 
addition, the superior ability of these methods to diagnose dyssynchrony may prove 
useful in risk-stratification and monitoring of other disease processes which affect the 







CHAPTER 1  
PROJECT SPECIFIC AIMS 
Introduction 
Synchronous contraction and relaxation of the myocardium is required to 
optimize cardiac function1. Regional timing of contraction and relaxation is 
dyssynchronous in many patients with severe congestive heart failure2, 3. Cardiac 
resynchronization therapy (CRT) is a relatively new treatment for dyssynchronous heart 
failure that results in both acute and long-term benefits4, 5. Patients are currently selected 
for CRT using surface electrocardiogram QRS duration as a measure of dyssynchrony. 
However, up to 30% of patients selected for CRT show no improvement5. This poor 
response rate may in part be explained by the poor correlation between mechanical 
dyssynchrony and QRS duration6. Thus, better methods to quantify mechanical 
dyssynchrony in the heart may improve the poor CRT response rate7. 
There are two primary approaches to quantifying mechanical dyssynchrony in the 
heart: 1) examine the dyssynchrony in the motion or contraction between multiple 
segments of the heart and 2) examine the dyssynchrony in the flow of blood in the left 
ventricle (LV) that is caused by dyssynchronous contraction of the myocardium. Each of 
these methods has its limitations which this project has attempted to improve upon. 
The motion of LV myocardium is most often quantified by Tissue Doppler 
velocity imaging (TDI). Many TDI-based methodologies to quantify dyssynchrony have 
been proposed, yet no single methodology has emerged as a widespread standard. Most 
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investigators utilize “time-to-peak” analysis where the time from the electrocardiogram 
Q-wave to the peak systolic velocity of one ventricular wall is compared to that of an 
opposing ventricular wall8, 9. This analysis may be limited by its quantitative simplicity: it 
utilizes only 1 data point from the 140 points typically collected per heart beat.  
To overcome this limitation, we developed a new mathematical method to 
calculate a temporal delay between two myocardial velocity curves. Our method utilizes 
a cross-correlation (XC) function to quantify either systolic, diastolic or whole-cycle 
cross-correlation delay (XCD) using TDI data collected throughout the cardiac cycle (not 
just peak values).  
The second approach to quantify mechanical dyssynchrony in the heart is to 
examine the dyssynchrony in the flow of blood within the LV. Ventricular dyssynchrony 
creates abnormal systolic flow patterns in the LV which results in a reduced efficiency of 
ventricular ejection due to blood flowing internally within the LV instead of moving 
directly through the LV and into the aorta10. This internal flow has been quantified by 
conductance catheter11 and used to demonstrate the benefit of CRT12. However, the 
clinical utility of this approach is currently limited by the invasive nature of 
catheterization. It may be possible to quantify internal flow non-invasively from regional 
volume curves of the LV derived from cardiac magnetic resonance (CMR) images. The 
ability to quantify internal flow non-invasively will greatly improve its potential clinical 
use and may provide a better physiologic measure of the effect of ventricular 





The objectives of this project were to 1) evaluate the ability of XC delays to 
diagnose mechanical dyssynchrony in the heart, and 2) develop a non-invasive method to 
quantify internal flow within the LV as a measure of dyssynchrony. We hypothesized 
that 1) XC delays are more sensitive and specific in diagnosing dyssynchrony compared 
to currently utilized methods for quantifying dyssynchrony and 2) internal flow can be 
quantified with cardiac magnetic resonance imaging and will be increased in patients 
with LV dyssynchrony compared to normal volunteers.  
The specific aims of this project were to: 
1) Quantify the effect of region of interest (ROI) tracking on the diagnosis of 
LV dyssynchrony from tissue Doppler images. Analysis was performed on 18 
patients who satisfied standard CRT enrollment criteria. Successful completion of 
this aim demonstrated that XC delays can be accurately quantified with a 
stationary region of interest and therefore require minimal post-processing time. 
2) Evaluate the ability of XC delays to discriminate between positive and 
negative control groups compared to previously published dyssynchrony 
parameters. Analysis was performed on 11 pre-CRT TDI exams from patients 
who showed a positive response to CRT (greater than 15% reduction in LV end-
systolic volume after 3 months of pacing). Negative controls were volunteers with 
no history of heart disease, normal echocardiogram and normal 12-lead 
electrocardiography. ROC analysis was performed to quantify each dyssynchrony 
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3) Evaluate the ability of XC delays to diagnose acute “pacing-induced 
dyssynchrony.” Dyssynchrony was created by pacing the right ventricular apex 
(RVA) of pediatric patients undergoing catheter ablation for non-preexcited 
supraventricular tachycardia. TDI exams were acquired during this 
dyssynchronous state and compared to TDI exams acquired during atrial pacing at 
the same rate as a negative control. ROC analysis was performed to quantify each 
dyssynchrony parameter’s ability to discriminate between atrial pacing and RVA 
pacing. Successful completion of this aim demonstrated that systolic XC delay 
showed the greatest ability to diagnose acute pacing-induced dyssynchrony. 
4) Develop and evaluate a new method for quantifying left ventricular internal 
flow from standard cine cardiac magnetic resonance images. Regional volume 
curves were generated for the LV using a semi-automated border detection and 
segmentation algorithm. Internal flow was calculated as the sum of the absolute 
changes in regional volume minus the absolute change in global LV volume. As a 
preliminary study, internal flow was quantified in patients with severely 
dyssynchronous (QRS>150 ms) class III/IV heart failure and a group of healthy, 
normal controls. Successful completion of this aim demonstrated that patients 
with dyssynchronous heart failure had nearly 6 times the internal flow present in 
healthy controls.   
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CHAPTER 2  
BACKGROUND AND INTRODUCTION TO NEW 
METHODOLOGY 
Background 
Cardiac Resynchronization Therapy 
Cardiac resynchronization therapy (CRT) utilizing biventricular pacemakers is a 
relatively new treatment for patients with end-stage, drug-refractory heart failure4, 5. CRT 
results in an acute hemodynamic benefit13-16, reverse ventricular remodeling,17-20 and 
improved quality of life4, 21, 22. This positive response to CRT was initially thought to 
derive from the resolution of inter-ventricular dyssynchrony (discoordinate contraction 
between the left and right ventricles). Therefore, patients with inter-ventricular 
dyssynchrony were chosen to receive CRT. It was shown that QRS duration measured on 
a surface electrocardiogram was a good marker for inter-ventricular dyssynchrony23. 
Consequently, patients with a wide QRS complex (> 120 ms) were enrolled in the initial 
randomized clinical trials of CRT5. Current selection criteria also require an ejection 
fraction <35%, New York Heart Association (NYHA) class III or IV heart failure5 and 
stable clinical condition despite optimal medical therapy for at least 3 months. 
However, specificity of current selection criteria is low, as 20 to 30% of selected 
patients do not respond to CRT5. Sensitivity is also low as some patients with heart 
failure have benefited from CRT despite the fact that they do not satisfy current selection 
criteria24. This becomes a critical issue as CRT is an invasive and expensive therapy with 
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each device costing from $25 – $40,000 and total per patient hospital charges 
approaching $100,00025, 26. These factors mandate the need for the development of more 
specific and sensitive patient selection criteria for CRT26, 27. 
Left ventricular (LV) dyssynchrony (dyssynchrony within the left ventricle) may 
better predict response to CRT27. Approximately 30% of patients with wide QRS lack LV 
dyssynchrony28. This may partially explain the low response rates in the initial CRT 
trials. In fact, the majority of recent evidence suggests that LV dyssynchrony is important 
in predicting response to CRT whereas inter-ventricular dyssynchrony is not useful7. 
 
Quantification of Left Ventricular Dyssynchrony 
Numerous techniques have been used to assess LV dyssynchrony27. However, no 
single method has emerged as a widespread standard. Conventional echocardiographic 
methods for measuring LV dyssynchrony include M-mode measurement of the septal-to-
posterior wall motion delay29, Fourier phase angle analysis of wall displacement30, and 
calculation of regional fractional area changes using contrast imaging31. As noted by Bax 
et al27, these techniques are restricted by the use of a single imaging plane and, therefore, 
do not quantify global LV dyssynchrony. Three-dimensional echocardiography and 
modeling can overcome this limitation32, but limited availability and prolonged time 
required for image processing has, up to now, limited its clinical applicability. 
Tissue Doppler velocity imaging (TDI) of the myocardium has recently emerged 
as a powerful tool to quantify LV mechanical dyssynchrony27. Using TDI, it is possible to 
obtain a time-varying velocity curve for a single ventricular wall at frame rates 
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approaching 300 Hertz (corresponding to one data point every 3.3 milliseconds). TDI 
assessment of the LV may represent the best method to diagnose dyssynchrony7.  
 
Quantification of Left Ventricular Dyssynchrony Using Tissue Doppler Imaging 
TDI has most often been used to quantify dyssynchrony as the simple difference 
in time-to-peak systolic myocardial velocity between the septum and lateral wall of the 
LV8, 33. This parameter is referred to as the septal-to-lateral delay (SLD). SLD greater 
than 60 ms predicted response to CRT with a sensitivity and specificity of 76 and 88%, 
respectively8. The maximal difference in time-to-peak velocity in any 2 of the 4 basal 
septal, lateral, anterior and inferior ventricular segments (MaxDiff) has also been used to 
quantify dyssynchrony34. A MaxDiff greater than 65 ms predicted response to CRT with 
a sensitivity and specificity of 92%34.  
Yu et al extended this “time-to-peak” analysis by using the standard deviation of 
times-to-peak systolic myocardial velocity of the 12 standardized LV mid-wall and basal 
segments (Ts-SD) as a measure of dyssynchrony19. This method has provided a global 
measure of LV dyssynchrony that can be calculated with moderate post-processing time. 
By quantifying Ts-SD in 88 normal subjects and taking the mean (17 ms) plus two 
standard deviations (2 * 7.8 = 15.6 ms) of Ts-SD in these normals, Yu et al determined a 
threshold value of 32.6 ms to diagnose LV dyssynchrony6. However, multiple threshold 
values for Ts-SD dyssynchrony have been reported by Yu et al. For instance, the authors 
used a threshold of 31.4 ms to predict response to CRT with a sensitivity and specificity 
of 96 and 78%, respectively35. In a different population of patients, Yu et al reported a 
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threshold of 34.4 ms to predict response to CRT with a sensitivity and specificity of 87 
and 81%, respectively36. 
 
Refinement of CRT Selection Criteria 
In a recent CRT review article, Bax et al suggested that it is mandatory to expand 
current guidelines for patient selection for CRT to include TDI assessment of LV 
dyssynchrony7. However, a recent study showed that the most commonly used TDI 
dyssynchrony parameters agree on the diagnosis of dyssynchrony only half the time37. In 
addition, the first multi-center trial to prospectively determine the ability of 
echocardiographic parameters (including tissue Doppler parameters) to predict response 
to CRT (PROSPECT)38 recently completed enrollment. The initial results showed that no 
parameter predicted response to CRT as hypothesized39.  
Thus, despite the success of echocardiographic parameters in predicting response 
to CRT in small, single-center studies, no parameter predicted response to CRT in the 
first multicenter trial. In addition, the PROSPECT trial showed poor reproducibility of 
echocardiographic parameters between the 2 core labs in the study. Therefore, better 
methods to diagnose mechanical dyssynchrony in the heart are needed. 
 
Limitations of Current Dyssynchrony Parameters  
There are three major limitations of existing dyssynchrony parameters which this 
thesis addresses. First, existing dyssynchrony parameters were all developed solely to 
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identify patients who will benefit from CRT7. There are many causes for a non-response 
to CRT in addition to the absence of baseline dyssynchrony7. Thus, discrimination of 
responders to CRT from non-responders is not equivalent to discrimination of 
synchronous contraction from dyssynchronous contraction. No dyssynchrony parameter 
has undergone rigorous scientific evaluation for diagnosis of dyssynchrony using positive 
and negative controls. 
Prior to determining whether CRT selection criteria should be expanded to 
include assessment of LV dyssynchrony by TDI, it is important to show that the 
dyssynchrony parameters are normal in negative control subjects and abnormal in 
positive control subjects with known mechanical dyssynchrony. This rigorous evaluation 
of dyssynchrony parameters can be performed in a model system of dyssynchrony such 
as “pacing-induced dyssynchrony.” In this model, dyssynchrony is created by pacing the 
right ventricular apex at a rate that overcomes intrinsic conduction. This “pacing-induced 
dyssynchrony” can be compared to normal, synchronous contraction at the same rate 
during atrial pacing as a negative control. 
The second limitation of current dyssynchrony parameters is that they are all 
quantitatively simplistic. For example, 8 TDI-based parameters (including those 
mentioned above) were compared in the PROSPECT trial38. Seven of these 8 parameters 
are based on a “time-to-peak” analysis where the time from the electrocardiogram Q-
wave to the peak velocity of a ventricular wall is compared to that of a different 
ventricular wall40. This “time-to-peak” analysis is quantitatively simplistic in that it 
utilizes only 1 data point from the 140 points typically collected per heart beat. 
Furthermore, it makes the assumption that the peak velocity is the most clinically 
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important component criterion of ventricular synchrony. This peak can also be difficult to 
identify as there are often two peaks of similar magnitude that occur at different times 
during systole. “Time-to-peak” analysis also focuses on systolic synchrony and 
disregards diastolic synchrony. 
Using a more advanced signal processing technique called a cross-correlation 
function, it may be possible to quantify the synchrony of contraction throughout systole 
and the synchrony of relaxation throughout diastole. By utilizing all data points on the 
velocity curves, cross-correlation analysis does not rely on peak values like “time-to-
peak” analyses. We hypothesized that cross-correlation analysis will provide a more 
robust measure of dyssynchrony than methods based on “time-to-peak” analysis and will 
ultimately assist in the refinement of current CRT selection criteria. 
 
Introduction to Cross-Correlation Analysis of Dyssynchrony 
A cross-correlation (XC) function is used in digital signal processing to calculate 
a temporal delay between two discrete-time signals with a constant time step between 
data points. Tissue Doppler myocardial velocity data collected from the same image in 
different locations essentially represents two discrete-time signals with the same time 
vector and different amplitudes where amplitude is equal to velocity. For example, from 
an apical 4-chamber tissue Doppler image, we can obtain the velocity curve from the 
basal septum and compare this to the velocity curve from the basal lateral wall using a 
cross-correlation function. Figure 2.1 shows two discrete-time signals acquired at 140 
frames per second with a time resolution of 7 milliseconds. The temporal delay between 
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the signals in Figure 2.1 was artificially set to 98 milliseconds in order to illustrate how 
the XC function works. The solid line signal is identical to the dashed line signal with 




Figure 2.1: Two discrete-time signals with a temporal delay of 98 ms. 
 
 
Now let x and y be the myocardial velocity vectors of the two curves in Figure 
2.1, with N data points, and a constant time differential between data points equal to Δt (7 
milliseconds in Figure 2.1). Note that the time length of the signals is then equal to N * Δt 
(~1000 milliseconds in Figure 2.1). Then the normalized cross-correlation function 
Cxy(m) can be calculated for any temporal delay, m, where m is an integer multiple of Δt: 
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Figure 2.2: Cross-correlation analysis determines the temporal delay to be 98 ms. 
 
 
where x  is the mean value of x and y  is the mean value of y. If we calculate the cross-
correlation function for each integer multiple of Δt within the range ±0.5*(heart period), 
the maximum of the cross-correlation function occurs at the actual temporal delay 
between the two signals. Figure 2.2A shows the cross-correlation function (Cxy) of the 
two signals in Figure 2.1 as a function of the temporal delay (m) between the signals. 
Figure 2.2B shows only the maximum peak from Figure 2.2A, and we can see that the 
two signals correlate maximally at the temporal delay we initially defined between them 
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(98 ms). Figure 2.3 shows the same signals from Figure 2.1 now plotted with the 
temporal shift of 98 ms as calculated by the cross-correlation function. After temporal 




Figure 2.3 The signals match in time after plotting them with the temporal delay 
determined using cross-correlation analysis. 
 
 
Calculation of Systolic and Diastolic Temporal Delays 
We can apply the cross-correlation function to any two velocity curves to 
calculate a temporal delay between them. In order to calculate systolic and diastolic 
temporal delays independently, we divide the myocardial velocity curves into systole and 
diastole using the timing of aortic and mitral valve opening and closing (Figure 2.4). This 
data can be obtained from pulsed Doppler images of the aortic and mitral valve outflow 
tracts which are routinely collected during an echocardiogram. We can use a cross-
correlation function to calculate a temporal delay for the systolic portion (from aortic 
valve opening to aortic valve closure) and diastolic portion (from mitral valve opening to 
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mitral valve closure) of the myocardial velocity curves independently. We can also 
calculate a temporal delay for the whole velocity curve. Therefore, the output of the 
cross-correlation comparison of two myocardial velocity curves is:  
1) Whole-cycle temporal delay,  
2) Systolic temporal delay, and  
3) Diastolic temporal delay.  
Each of these parameters can be calculated and compared to determine which one 




Figure 2.4: Myocardial velocity curves divided into systolic and diastolic portions. 
 
 
Estimation of Global Dyssynchrony 
In order to estimate global dyssynchrony, we calculate the temporal delay 
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between opposing basal segments in apical 2-, 3- and 4-chamber views and take a 
maximum of these values. This will be a maximum of 3 temporal delays. For example, 
Figure 2.5 shows an apical 4-chamber view of the LV with oval 30x6mm regions of 
interest (ROIs) placed in the basal segments of the septum and lateral wall. The ROI 
represents the area over which Doppler-derived velocity data will be averaged in order to 
output the myocardial velocity curve. We calculate the 4-chamber temporal delay as the 
cross-correlation temporal delay between the basal septum and basal lateral wall ROIs. 
From each apical view we obtain a temporal delay from the opposing basal segments. 
Therefore, using the three standard apical views, we obtain 3 temporal delays and take a 








Automated Quantitative Analysis  
The quantitative data analysis described above has been programmed into a 
 15
quantitative analysis software package (MatLab version 7.40 from MathWorks, Inc., 
Natick, MA). We can export tissue Doppler myocardial velocity data from commercially 
available EchoPAC PC SW software (version 4.0.3, GE Vingmed Ultrasound, Horten, 
Norway). This data can then be uploaded into MatLab and processed using MatLab 
programs that we have written and optimized in order to automate the analysis. This 
automated analysis is intended to minimize human error during data processing. 
 
Hemodynamic Quantification of Ventricular Dyssynchrony  
There are two approaches to quantification of LV dyssynchrony. We have 
discussed methods to automate and improve upon quantification of LV dyssynchrony 
using TDI-based motion analysis of the myocardium. Another approach to quantifying 
LV dyssynchrony is to examine the dyssynchrony in blood flow created by 
dyssynchronous motion of the ventricular walls. This hemodynamic approach may 
represent a more direct physiological measure of dyssynchrony than parameters based on 
wall motion analysis.  
Paradoxical systolic flow toward late-activated or dyssynchronous segments has 
been reported and quantified previously using Doppler echocardiography of blood flow 
in the LV10, 41. In addition, reversed diastolic flow towards the LV base has been 
observed in patients with anterior wall ischemia42, presumably due to dyssynchronous 
contraction caused by ischemia. Thus, the underlying pathophysiology of dyssynchrony 
is a reduced efficiency of ventricular ejection due to blood flowing internally or within 
the LV instead of moving directly through the LV and into the aorta.  
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Internal flow can be quantified by conductance catheter and expressed as a 
percentage of the total ejected volume (referred to as the internal flow fraction)11. 
Steendijk et al demonstrated that patients with LBBB had an internal flow fraction of 
78% compared to only 20% in normal controls11. A recent study also showed that internal 
flow fraction was reduced from 71% to 42% after 6 months of CRT12. Thus, 
quantification of internal flow has shown promise in identifying dyssynchrony and in 
demonstrating the hemodynamic benefit of CRT. 
Internal flow can be calculated from regional volume versus time curves for any 
number of regional volumes of the LV: 
( )












where IF(t) is the internal flow at time t, Vi(t) is the volume of segment i at time t, and 
VLV(t) is the volume of the entire LV at time t11: 
( )∑=
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(2-3) 
Note that division of equation (2) by 2 takes into account the fact that any blood 
which exits one regional volume must enter another regional volume if it does not leave 
the LV. Internal flow fraction (IFF) is defined as the total internal flow divided by the 
stroke volume. IFF can be calculated in systole (IFFsystole), diastole (IFFdiastole) and over 
the entire cardiac cycle (IFFwhole).  
The clinical utility of internal flow analysis is currently limited by the invasive 
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catheterization procedure required for its calculation. However, we can generate regional 
volume versus time curves for the LV using cardiac magnetic resonance (CMR) imaging 
to enable non-invasive quantification of IFF. This will represent a significant step 
forward in making hemodynamic quantification of LV dyssynchrony more useful and 
readily available to assist in diagnosis and treatment of LV dyssynchrony. 
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CHAPTER 3  
AIM 1: QUANTIFY THE EFFECT OF REGION OF INTEREST 
TRACKING ON THE DIAGNOSIS OF LEFT VENTRICULAR 
DYSSYNCHRONY FROM TISSUE DOPPLER IMAGES 
Introduction 
Left ventricular mechanical dyssynchrony can be diagnosed using tissue Doppler 
imaging (TDI) of the myocardium.27 Diagnosis of dyssynchrony with TDI requires two 
main post-processing steps which have not been standardized. First, velocity-time curves 
are generated from myocardial segments by placing regions of interest (ROIs) within 
both the mid-ventricular and basal segments of the LV walls.43 Manual “tracking” of the 
ROI throughout the cardiac cycle is performed to ensure that the ROI remains in a mid-
myocardial location. Tracking is required to generate the true shape of the myocardial 
velocity curve, but is time consuming and typically not performed when diagnosing 
dyssynchrony.44 Importantly, many authors have omitted the description of whether or 
not ROI tracking was employed.6, 8, 9, 20, 28, 34-36, 45, 46 
The second post-processing step required to diagnose dyssynchrony using TDI is 
to compare the velocity-time curves from different myocardial walls to generate a 
quantitative value of dyssynchrony. Unfortunately, there is no accepted parameter for 
calculating dyssynchrony. Most methods utilize parameters based on a time-to-peak 
analysis where the time from the electrocardiogram Q-wave to the peak systolic velocity 
is measured in each segment of the LV. A simple difference in this time-to-peak ≥60ms 
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between the basal septal and lateral segments can be used to define dyssynchrony.8 We 
developed systolic, diastolic and whole-cycle cross-correlation delay (XCD) parameters 
which utilize all velocity data points from 3 consecutive beats (~420 points) to quantify 
dyssynchrony.  
Dyssynchrony parameters are typically calculated from velocity-time curves 
generated from a stationary ROI. A stationary ROI generates a slightly different velocity-
time curve than a tracked ROI because the stationary ROI includes regions of the 
ventricular cavities (outside the myocardial segment of interest) during part of the cardiac 
cycle. For example, Figure 3.1 shows an ROI placed in the basal septum of a patient with 
heart failure. The ROI includes some of the right ventricular cavity at end-systole and 
some of the left ventricular cavity at end-diastole. Inclusion of data from the ventricular 
cavities may lead to a change in the location of the peak systolic velocity, which may 
affect the diagnosis of dyssynchrony. No study to date has examined the effect of manual 




Figure 3.1: The myocardium moves into and out of a stationary region of interest 




We hypothesized that using a stationary ROI to quantify dyssynchrony from TDI 
would affect the diagnosis of dyssynchrony in patients with heart failure. We tested our 
hypothesis by quantifying dyssynchrony using both tracked and stationary ROIs in 18 
patients with heart failure who were being evaluated for CRT. We examined the effect of 





Consecutive patients referred to Emory University Crawford Long Hospital for 
potential treatment with CRT were evaluated for inclusion. Inclusion criteria were: 1) left 
ventricular ejection fraction <35%, 2) QRS duration > 120ms, and 3) New York Heart 
Association (NYHA) class III or IV heart failure. Twenty patients satisfied criteria and 
were enrolled initially. However, subsequent testing revealed that one patient had a QRS 
duration of 96 ms and another had an ejection fraction of 57%. These two patients were 
excluded. Characteristics of the final 18 patients are shown in Table 3.1. All patients gave 




Table 3-1: Characteristics of the patient population. 
Variable (units) Value (mean ± SD, n = 18) 
Age (years) 58 ± 16 
Male gender (%) 9 (50%) 
LV end systolic volume (ml) 115 ± 51 
LV end diastolic volume (ml) 165 ± 64 
LV ejection fraction (%) 31 ± 10 
QRS duration (ms) 183 ± 36 
 
 
Tissue Doppler Data Acquisition 
Apical 2-, 3- and 4-chamber TDI of the myocardium were acquired with the 
patient lying in the lateral decubitus position using a commercial system (Vivid 7, GE 
Vingmed, Horten, Norway). The myocardial walls were aligned as parallel to the Doppler 
beam as possible to minimize the angle of insonation, and frame rate was optimized from 
100 to 140 Hertz. Pulsed Doppler spectral recordings of the aortic outflow tract were 
acquired for definition of systole. 
 
Tissue Doppler Post-processing 
EchoPAC PC SW post-processing software (version 4.0.3, GE Vingmed, Horten, 
Norway) was used to export velocity data from the 12 basal and mid-wall segments of the 
6 standard LV walls (septum and lateral walls in 4-chamber view, anteroseptal and 
posterior walls in 3-chamber view, and anterior and inferior walls in 2-chamber 
 22
view). The curves were processed with the default averaging filter (30ms) within the 
EchoPAC software prior to export. Velocity data was exported using two methods for 
comparison: 
(1) Tracked ROIs: A 30x6-millimeter ROI was located over the mid-wall of the 
myocardium and was moved manually throughout the cardiac cycle to 
maintain this mid-wall location within the ventricular segment of interest. 
(2) Stationary ROIs: A 30x6-millimeter ROI was placed at the center of motion of 
the ventricular segment of interest. 
Six dyssynchrony parameters were calculated from the exported velocity curves:  
(1) basal septal-to-lateral delay in time-to-peak systolic velocity (SLD)8  
(2) maximum difference in times-to-peak systolic velocity between any 2 of the 
basal septal, lateral, anterior and inferior LV segments (MaxDiff)33 
(3) the standard deviation of times-to-peak systolic velocity in the 12 basal and 
mid-wall segments of the LV (Ts-SD)19 
(4) Systolic XCD - The maximum cross-correlation temporal delay between the 
systolic portion of the myocardial velocity curves from opposing basal 
sections in apical 2-, 3- and 4-chamber views. Systole was defined to include 
the isovolumic contraction period from mitral valve closure to aortic valve 
closure. 
(5) Diastolic XCD - Diastolic XCD was calculated similarly to systolic XCD, 
except the diastolic portion of the velocity curve was used. Diastole was 
 23
defined to include the isovolumic relaxation period from aortic valve closure 
to mitral valve closure. 
(6) Whole-cycle XCD - The maximum cross-correlation temporal delay between 
myocardial velocity curves from opposing basal sections in apical 2-, 3- and 
4-chamber views.  
Prior to cross-correlation processing, the velocity curves were bilinearly 
interpolated so that there was a constant time step between data points for each subject.  
Each dyssynchrony parameter was calculated twice for each patient: first using 
velocity curves from the tracked ROIs and second using velocity curves from the 
stationary ROIs. An average velocity curve was generated from three cardiac cycles of 
velocity data prior to measuring dyssynchrony parameters. Pulsed Doppler of the aortic 
outflow tract was used to define systole for identification of the peak systolic velocity for 
calculation of time-to-peak parameters.   
 
Correction for Heart Rate 
Dyssynchrony parameters were normalized by the square root of the R-R interval 
in seconds to normalize for differences in heart rate. 
 
Statistics 
Bland-Altman plots were generated to demonstrate the agreement between 
calculating dyssynchrony using tracked versus stationary ROIs for each of the 6 
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dyssynchrony parameters. Paired student’s t-tests were used to compare dyssynchrony 
derived from tracked versus stationary ROIs for each of the 6 dyssynchrony parameters. 
A value of p<0.05 was defined as statistically significant. Threshold values to diagnose 
dyssynchrony were used to determine whether use of a stationary ROI changed the 
diagnosis of dyssynchrony for any patients.  
 
Results 
Bland-Altman Agreement Between Tracked and Stationary ROIs 
Results for each patient are shown (Tables 3.2 and 3.3). There was no significant 
difference in mean values for tracked versus stationary ROI analysis for any 
dyssynchrony parameter (Table 3.4).  
Bland-Altman analysis (Figure 3.2) demonstrated excellent agreement between 
stationary and tracked ROIs for the XCD parameters (2*SD of the mean difference = 
11ms, 11ms and 10 ms, respectively for whole-cycle, systolic and diastolic XCD). The 
agreement was poor for the time-to-peak dyssynchrony parameters (2*SD of the mean 
difference = 74, 71, 18 ms, respectively, for SLD, MaxDiff and Ts-SD).  
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Table 3-2: Dyssynchrony values for time-to-peak parameters using tracked versus 
stationary regions of interest. 
SLD (threshold = 60ms) MaxDiff (threshold = 65 ms) Ts-SD (threshold = 34.4 ms) Patient 
Number 
Tracked  Stationary  Tracked  Stationary Tracked Stationary 
1 94 94 110 110 46 48 
2§ 30 30 80 176 30 63 
3 68 76 107 107 61 62 
4 66 66 83 76 50 50 
5 109 109 116 116 62 64 
6 77 77 116 116 51 54 
7 0 0 15 15 45 45 
8* 105 16 119 111 68 65 
9 122 114 168 152 78 77 
10*†§ 0 134 17 135 31 55 
11 73 73 94 102 47 46 
12 0 0 44 44 24 24 
13 6 6 20 20 34 34 
14 21 21 57 57 45 44 
15 15 15 25 25 27 27 
16 7 7 36 36 35 37 
17 16 16 16 16 27 27 
18 7 0 16 9 31 30 
Threshold values for diagnosing dyssynchrony are given in the column headers for each parameter. *Use of 
a stationary region of interest changed the diagnosis of dyssynchrony according to SLD. †Use of a 
stationary region of interest changed the diagnosis according to MaxDiff. §Use of a stationary region of 




Table 3-3: Dyssynchrony values for the XC delay parameters using tracked versus 
stationary regions of interest. 
Whole-XCD  
(threshold = 25 ms) 
Systolic-XCD  
(threshold = 53 ms) 
Diastolic-XCD  
(threshold = 22 ms) 
Patient 
Number 
Tracked Stationary Tracked  Stationary Tracked Stationary 
1 23 23 38 46 15 15 
2 10 10 91 91 29 29 
3 150 150 32 39 158 158 
4 45 45 110 81 36 36 
5 90 90 90 90 90 90 
6 5 5 58 58 5 5 
7 45 45 133 133 37 37 
8* 23 23 93 93 23 16 
9 92 100 146 146 69 69 
10 60 40 0 7 60 60 
11 171 171 139 139 170 170 
12 67 67 15 15 99 82 
13 64 71 28 28 92 99 
14 21 21 85 85 28 21 
15 44 44 51 51 44 44 
16 21 21 36 43 7 7 
17 49 57 16 16 227 219 
18 300 300 0 0 30 30 
Threshold values for diagnosing dyssynchrony are given in the column headers for each parameter. *Use of 












Disagreement on Diagnosis 
between Tracked and Stationary 
SLD 40 ± 37 43 ± 42 0.76 60 11 % 
MaxDiff 62 ± 40 73 ± 49 0.23 65 6 % 
Ts-SD 40 ± 12 43 ± 13 0.14 34.4 11 % 
Whole-XCD 65 ± 67 65 ± 67 0.99 25 0 % 
Systolic-XCD 59 ± 42 59 ± 41 0.82 53 0 % 
Diastolic-XCD 62 ± 55 60 ± 54 0.17 22 6 % 






Figure 3.2: XCD shows the closest agreement between tracked and stationary ROIs 
 
 
Effects of Tracking on the Diagnosis of Dyssynchrony 
ROI tracking did not affect the diagnosis of dyssynchrony in any patients when 
using whole-cycle or systolic XCD (Table 3.4). ROI tracking changed the diagnosis of 
dyssynchrony in only one patient when using diastolic XCD. However, ROI tracking 
changed the diagnosis of dyssynchrony in 2, 1 and 2 of the patients when using SLD, 
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MaxDiff and Ts-SD, respectively (Table 3.4). For example, Figure 3.3A shows velocity 
curves from the basal septum and lateral wall of patient number 10 using tracked ROIs. 
Figure 3.3B shows velocity curves from the same patient using stationary ROIs placed in 
the same segment as the tracked ROIs. The patient had a SLD of 0 ms using tracked ROIs 
compared to a SLD of 141 ms using stationary ROIs. Since the threshold value for 
diagnosing dyssynchrony with SLD is 60 ms, the stationary ROI suggested that the 
patient had dyssynchrony while the tracked ROI demonstrated that the patient did not 









Tissue Doppler imaging (TDI) of the myocardium is a powerful tool to diagnose 
LV mechanical dyssynchrony.27 Dyssynchrony is diagnosed by placing sample volumes, 
or regions of interest (ROIs), in several ventricular segments and comparing the velocity 
tracings from these segments. Manual tracking of the ROIs needs to be performed to 
maintain the location of the ROI within the segment of interest as the heart moves. 
However, the process of manual tracking is time-consuming and not typically done.44 We 
showed that using a stationary ROI changed the diagnosis of dyssynchrony in 6-11% of 
patients with advanced heart failure using time-to-peak dyssynchrony parameters while 
use of a stationary ROI did not affect the diagnosis using whole-cycle and systolic cross-
correlation delay analysis. This is the first study to report the effects of ROI tracking on 
the diagnosis of dyssynchrony.  
 
Region of Interest Tracking in Other TDI Dyssynchrony Studies 
The significance of ROI tracking on dyssynchrony indices has been largely 
ignored in the literature. Ten of the most commonly cited studies using color TDI to 
measure ventricular dyssynchrony6, 8, 9, 20, 28, 34-36, 45, 46 failed to specify whether the 
authors used a tracked or stationary ROI. (However, in a correspondence letter, Yu et al 
stated that their group always uses a tracked ROI.47) Studies using pulsed TDI to quantify 
dyssynchrony33, 48-50 all use stationary ROIs as software has not been developed to 
reconstitute velocity tracings with a tracked pulsed Doppler ROI. Our study suggests that 
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ROI tracking is important and should be addressed in future TDI dyssynchrony studies. 
The predictors of response to CRT (PROSPECT) trial is the first international, 
multi-center study using TDI dyssynchrony measures to predict response to CRT.38 The 
PROSPECT trial showed that no TDI dyssynchrony parameter predicted response to 
CRT39. However, the PROSPECT echocardiography core labs used a stationary ROI to 
quantify dyssynchrony. We have shown that quantification of dyssynchrony using 
stationary ROIs is suboptimal when using time-to-peak parameters, and this may partially 
account for the negative results of the trial. 
Studies using strain rate imaging to quantify dyssynchrony have reported using a 
tracked ROI for analysis.51, 52 Since Doppler-derived strain rate is calculated with a 
velocity gradient, velocity must be measured accurately in two places within the 
myocardium. Thus, we expect that strain rate imaging will be more susceptible to ROI 
tracking than velocity-based measures of dyssynchrony. 
 
Correction for Heart Rate 
We corrected for heart rate by dividing dyssynchrony values by the square root of 
the R-R interval for each patient. We chose to do this to facilitate comparison of 
dyssynchrony values across the different chapters in this thesis (the pediatric patients in 
Chapter 5 had heart rates that were much higher than the typical adult patients from 
Chapters 3, 4 and 6). However, published threshold values used to diagnose 
dyssynchrony with the time-to-peak parameters were not developed from datasets that 
were corrected for heart rate. Using un-corrected dyssynchrony values, the diagnosis of 
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dyssynchrony changed due to use of a stationary ROI in 17, 11 and 17% of the patients 
according to SLD, MaxDiff and Ts-SD (compared to 11, 6 and 11% using corrected 
values). Values from the un-corrected data may represent a more clinically relevant 
estimation of the error due to use of a stationary ROI in time-to-peak diagnosis of 
dyssynchrony from tissue Doppler images.  
 
Comparison to Existing Studies 
The mean values of dyssynchrony in our study compare well with previous 
reports. Yu et al19 reported a Ts-SD of 38 ± 11 ms in a group of 25 patients undergoing 
CRT compared to 40 ± 12 ms in our group of 18 patients. Bax et al34 reported a value of 
73 ± 49 ms for MaxDiff in a group of 85 patients receiving CRT, which was identical to 
that seen in our study. SLD shows variability in the literature as Bax et al reported a value 
of 71 ± 38 ms in 25 patients with heart failure8 and 97 ± 35 ms in a different group of 22 
patients.9 In another study, Yu et al20 reported a mean SLD of 36 ms in a group of 30 
heart failure patients, which compares well with the value of 40 ± 37 ms in our group of 
patients.  
 
Cross-correlation Delay versus Time-to-peak Parameters for Quantification of 
Dyssynchrony 
The majority of techniques to assess LV dyssynchrony utilize “time-to-peak” 
analysis where the time from the QRS onset to the peak velocity of a ventricular wall is 
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compared to that of a different ventricular wall.8 Using TDI, it is possible to obtain 
velocity curves from two ventricular walls simultaneously at frame rates over 140 Hertz. 
Therefore, when analysis is limited to time-to-peak systolic myocardial velocity, only one 
of approximately 140 data points per heart cycle is utilized. XCD analysis overcomes this 
limitation by utilizing all data (~420 points from 3 consecutive heart beats) from the 
myocardial velocity curves to quantify dyssynchrony as opposed to just peak values. 
Therefore it is not surprising that XCD is less vulnerable to the slight errors caused by the 
myocardium being outside of the stationary ROI for brief periods during the cardiac 
cycle.  
The results of this study demonstrate a significant advantage of XCD while at the 
same time highlighting a weakness in conventional time-to-peak parameters. XCD 
dyssynchrony can be diagnosed with a stationary ROI while a tracked ROI should be 
used to measure conventional time-to-peak parameters. Thus, XCD can be calculated 
approximately 30 minutes faster per patient than time-to-peak parameters when using 
current commercially-available software platforms. 
 
Automation of Region Tracking 
The main deterrent from performing ROI tracking is the prolonged time required 
to complete the analysis. Manual ROI tracking added approximately 30 minutes of post-
processing time per patient in our study. However, new speckle tracking technology 
which enables manual tracking of the myocardium in 2 dimensions53 could be utilized to 
perform automated ROI tracking in future TDI post-processing software platforms. A 
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recent study implemented this technique and showed its feasibility.54 
 
Study Limitations 
Since there is no gold standard for diagnosing dyssynchrony, a limitation of our 
study is that it was unknown whether or not each patient in this study did or did not have 
dyssynchrony. Thus, we could not compare the performance of the 4 dyssynchrony 
parameters in diagnosing dyssynchrony. However, a comparison of the accuracy of each 
parameter in diagnosing dyssynchrony was performed in Aim 2 which is reported in 
Chapter 4 of this thesis.  
The true impact of ROI tracking on dyssynchrony assessment may be 
underestimated in this study as we only included patients with severe heart failure. These 
patients may have different or less myocardial motion than patients with either normal 
hearts or less severe disease. Further studies are needed to determine whether the 
amplitude of myocardial motion causes differing errors when stationary ROIs are used to 
diagnose dyssynchrony. 
Five patients in our study had a left ventricular ejection fraction less than 35% 
quantified by short-axis M-mode but between 35 and 41% as quantified by a Simpson’s 
bi-plane analysis. We chose not to exclude these patients since inclusion criteria for CRT 
include ejection fraction < 35% typically quantified by M-mode. However, we reported 





Use of a stationary region of interest (ROI) changes the diagnosis of 
dyssynchrony in 6-11% of patients when using conventional Doppler tissue imaging 
time-to-peak parameters such as septal-to-lateral delay. Cross-correlation delay (XCD) 
diagnosis of dyssynchrony is minimally affected by use of a stationary region of interest. 
These data demonstrate that using a stationary region of interest may be inaccurate 
approximately 11-17% of the time when using time-to-peak parameters to quantify 
dyssynchrony. However, cross-correlation delay dyssynchrony can be diagnosed 
accurately using stationary regions of interest, which saves post-processing time. 
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CHAPTER 4  
AIM 2: EVALUATE THE ABILITY OF XCD TO DISCRIMINATE 
BETWEEN POSITIVE AND NEGATIVE CONTROL GROUPS 




As mentioned in Chapter 3, there are two main steps required to quantify 
dyssynchrony from tissue Doppler images that have not been standardized. First, 
velocity-time curves are generated from myocardial segments by placing regions of 
interest (ROIs) within the different myocardial segments.43 Manual “tracking” of the ROI 
needs to be performed to ensure that the ROI remains in a mid-myocardial location, but is 
rarely performed since it is very time-consuming. The results of Chapter 3 showed that 
the XC delay parameters can be accurately quantified without tracking the ROI.  
The second post-processing step required to diagnose dyssynchrony using TDI is 
to compare the velocity-time curves from different myocardial walls to generate a 
quantitative value of dyssynchrony. This Chapter will compare the diagnostic accuracy of 
several published dyssynchrony parameters to the XC delay parameters in order to 
standardize this second post-processing step. 
The majority of techniques to assess LV dyssynchrony utilize tissue Doppler 
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velocity imaging (TDI) of the myocardium and are based on a “time-to-peak” analysis.7 
A recent study showed that the most commonly used dyssynchrony parameters agree on 
the diagnosis of dyssynchrony only half the time.37 This lack of agreement may be due to 
the quantitative simplicity of “time-to-peak” parameters. In ”time-to-peak” analysis, the 
time from the electrocardiogram Q-wave to the peak velocity of a ventricular wall is 
compared to that of a different ventricular wall, or walls.8 Using TDI, it is possible to 
obtain the time-dependent velocity of two ventricular walls simultaneously at frame rates 
over 140 Hertz (one data point every 7 milliseconds). Therefore, when analysis is limited 
to time-to-peak systolic myocardial velocity, only one of approximately 140 data points 
per heart cycle is utilized.  
To overcome this limitation, we developed a new mathematical method to 
calculate a temporal delay between two myocardial velocity curves. Our method utilizes 
a cross-correlation (XC) function to quantify either systolic, diastolic or whole-cycle 
cross-correlation delay (XCD) using TDI data collected throughout the cardiac cycle (not 
just peak values). We hypothesized that XC delays would provide a more accurate 
measure of dyssynchrony than methods based on “time-to-peak” analysis and will 
ultimately assist in the refinement of CRT selection criteria. We tested this hypothesis by 
comparing the ability of XC delays and other published dyssynchrony parameters to 
quantify dyssynchrony in groups of positive controls with known dyssynchrony and 





Positive Controls (Responders to CRT) 
Eleven positive controls were identified retrospectively from a database of 
patients who have received CRT at Emory University Crawford Long Hospital. Inclusion 
criteria were: 1) TDI and 2-dimensional echocardiogram at baseline and 3 months after 
CRT, 2) clinical evaluation at baseline and 3 months after CRT including 6-minute hall 
walk, quality of life score according to the Minnesota Living with Heart Failure 
questionnaire, and NYHA classification, 3) a positive response to CRT defined as a 
decrease in LV end-systolic volume of at least 15% 3 months after pacemaker 
implantation. All patients fit standard CRT selection criteria of ejection fraction <35%, 
QRS duration ≥120ms, and NYHA class III or IV heart failure. Patients with atrial 
fibrillation or chronic RV pacing were not excluded. Patients had a mean age of 68±14 
years and 8/11 were male. Five patients had ischemic etiology, 4 had a right-ventricular 
pacemaker at baseline and one patient had atrial fibrillation. Implantation and 
programming of the CRT device followed standard procedures previously described.40 
 
Negative Controls 
Twelve adult volunteers (mean age 29±7 years) with no known history of cardiac 
disease, a normal 2-D echocardiogram and normal 12-lead electrocardiogram were 
identified as negative controls. All subjects gave informed consent under guidelines 




Ejection fraction was quantified using the modified Simpson’s rule. End-systolic 
and end-diastolic dimensions were measured from M-mode parasternal short axis mid-
papillary images. Mitral regurgitation was quantified as the average area of the jet on 
color flow Doppler from apical 2- and 4-chamber views and also as the ratio of the jet to 
left atrial area in both views. 
 
Tissue Doppler Data Acquisition 
Apical 2-, 3-, and 4-chamber tissue Doppler images of the myocardium were 
acquired with a Vivid 7 system (GE Vingmed, Horten, Norway). The myocardial walls 
were aligned parallel to the Doppler beam to minimize the angle of insonation, and frame 
rate was optimized from 100 to 140 Hertz. Pulsed Doppler images of the aortic outflow 
tract were acquired for post-processing. 
 
Tissue Doppler Post-processing 
All studies were confirmed to be technically adequate by an independent 
cardiologist. EchoPAC PC post-processing software (version 4.0.3, GE Vingmed, 
Horten, Norway) was used to export velocity curves from the TDI data. An average 
velocity curve was generated from three cardiac cycles of velocity data prior to 
measuring times-to-peak. Pulsed Doppler of the aortic outflow tract was used to define 
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systole. Myocardial velocity data was exported from the 12 basal and mid-wall segments 
of the LV using a stationary, 30x6mm oval region of interest.  
Times-to-peak systolic velocities were automatically identified by a computer 
program written in MatLab quantitative analysis software (version 7.10, MathWorks, 
Inc., Natick, MA). This program imported velocity curves and aortic valve opening and 
closure from the EchoPAC software and exported the time from the Q-wave to the 
maximum velocity in the ejection phase. This was done to eliminate any error due to 
observer bias in selection of peak velocities.  
Three published dyssynchrony parameters were calculated from these times-to-
peak values: 1) basal septal-to-lateral delay in time-to-peak systolic velocity (SLD)8, 2) 
maximum difference in times-to-peak systolic velocity between any 2 of the basal septal, 
lateral, anterior and inferior LV segments (MaxDiff)33, and the standard deviation of 
times-to-peak systolic velocity in the 12 basal and mid-wall segments of the LV (Ts-
SD).19 
 
Estimation of Global Dyssynchrony Using Cross-correlation 
Three contiguous cycles of velocity data were exported from the basal segments 
of the 6 standard LV walls (septum and lateral walls in 4-chamber view, anteroseptal and 
posterior walls in 3-chamber view, and anterior and inferior walls in 2-chamber view). 
Velocity curves were imported into MatLab. Prior to cross-correlation processing, the 
velocity curves were bilinearly interpolated so that there was a constant time step 
between data points for each subject. The normalized cross-correlation spectrum was 
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computed between two velocity curves by shifting one curve in time relative to the other 
curve and computing the normalized correlation between the curves for each time shift. A 
normalized correlation value of 1 therefore meant the two curves were perfectly 
synchronous in time while a value of –1 meant the two curves were completely 
dyssynchronous. The time shift between the two curves that resulted in the maximum 
correlation value was defined as the temporal delay between the two curves. This 
temporal delay was calculated from opposing basal ventricular segments in each apical 
view (i.e. the temporal delay derived from the cross-correlation spectrum was calculated 
for the septal versus lateral basal velocity curves, the anterior versus inferior basal 
velocity curves, and the anteroseptal versus inferolateral basal velocity curves). Global 
dyssynchrony was defined as the maximum absolute value of these three temporal delays. 
This maximum delay is referred to as the cross-correlation delay (XCD) and was 
calculated with three different datasets: 
1. Whole-cycle XCD – The maximum cross-correlation temporal delay between 
myocardial velocity curves from opposing basal sections in apical 2-, 3- and 4-
chamber views. This represents a maximum of three cross-correlation temporal 
delays (one delay between the velocity curves from the two opposing basal 
segments in each of the three apical views).  
2. Systolic XCD – The maximum cross-correlation temporal delay between the 
systolic portion of the myocardial velocity curves from opposing basal sections in 
apical 2-, 3- and 4-chamber views. Systole was defined to include the isovolumic 
contraction period from mitral valve closure to aortic valve closure. 
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3. Diastolic XCD – Diastolic XCD was calculated similarly to systolic XCD, except 
the diastolic portion of the velocity curve was used. Diastole was defined to 
include the isovolumic relaxation period from mitral valve closure to aortic valve 
closure. 
 
Comparison to Existing TDI Dyssynchrony Parameters 
It is important to note that SLD, MaxDiff and Ts-SD were calculated with the 
same velocity curves used to calculate XCD. Dyssynchrony parameters were compared 
by their ability to discriminate between the positive and negative control groups with a 
numerical threshold. In addition, dyssynchrony was assessed in the positive control group 
3 months after pacemaker implantation to determine whether each dyssynchrony 
parameter was reduced after CRT.  
 
Correction for Heart Rate 
Dyssynchrony parameters were normalized by the square root of the R-R interval 
in seconds to normalize for differences in heart rate.  
 
Statistics 
SPSS version 15.0 (SPSS Inc., Chicago, IL) was used to calculate the area under 
the ROC curve as a measure of a parameter’s ability to discriminate between the positive 
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and negative controls. Areas under the ROC curve were statistically compared using the 
method described by Hanley and McNeil.55 The mean values of each parameter in the 
positive and negative controls were compared with an un-paired t-test. Baseline and 3-
month post-CRT values of dyssynchrony were compared for each parameter using a 
paired t-test. A value of p<0.05 was defined as statistically significant.  
 
Results 
Negative Control Group 
Table 4.1 shows the mean dyssynchrony and percentage of negative controls 
exhibiting dyssynchrony according to each parameter. SLD, MaxDiff and Ts-SD showed 
dyssynchrony in 5, 6 and 7 out of the 12 negative controls, respectively. Whole-cycle 
XCD showed dyssynchrony in zero subjects. Systolic and diastolic XCD showed 
dyssynchrony in 3 and 1 subject, respectively. Figure 4.1 shows an example of a 
representative negative control who exhibited dyssynchrony according to all the time-to-





Table 4-1: Dyssynchrony parameters in the negative control group. 






SLD 48 ± 41 60 42 % 
MaxDiff 56 ± 43 65 50 % 
Ts-SD 28 ± 16 34.4 58 % 
Whole-XCD 9 ± 5 25 0 % 
Systolic-XCD 29 ± 27 53 25 % 
Diastolic-XCD 14 ± 7 22 8 % 
*Values are means ± SD, n = 12. †Determined from ROC analysis in Figure 4.7 for XCD parameters, taken 






Figure 4.1: A negative control subject shows dyssynchrony according to all parameters 
except XCD. Red arrows show the location of the peak systolic velocities. 
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Table 4-2: Patient characteristics before and after CRT.  
Variable Pre-CRT Post-CRT p Value* 
Dyssynchrony parameters    
SLD (ms) 49 ± 41 81 ± 49 0.182 
MaxDiff (ms) 85 ± 42 111 ± 45 0.127 
Ts-SD (ms) 70 ± 18 64 ± 18 0.531 
Whole-XCD (ms) 160 ± 113  119 ± 30 0.442 
Systolic-XCD (ms) 110 ± 75  106 ± 47 0.809 
Diastolic-XCD (ms) 124 ± 105  55 ± 43 0.028 
Echocardiographic measurements    
LV end-systolic volume (ml) 145 ± 76 88 ± 38 0.002 
LV end-diastolic volume (ml) 188 ± 84 139 ± 47 0.004 
LV end-systolic dimension (cm) 5.9 ± 1.1 4.9 ± 1.7 0.01 
LV end-diastolic dimension (cm) 6.6 ± 1.1 6.0 ± 1.7 0.161 
LV ejection fraction (%) 24 ± 7 37 ± 10 < 0.001 
Mitral regurgitation area (cm2) 7.4 ± 4.5 5.2 ± 3.8 0.082 
Ratio of mitral regurgitation area to left atrial area (%) 34 ± 17 23 ± 15 0.06 
QRS Duration (ms) 175 ± 23 160 ± 27 0.18 
NYHA Class 3.1 ± 0.3 1.8 ± 0.8 < 0.001 
Quality of life score† 54 ± 27 26 ± 29 0.007 
6 minute hall walk (m) 227 ± 127 327 ± 103 0.055 
Values are means ± SD, n = 11. *p value from paired t-test. †according to the Minnesota Living with Heart 
questionnaire. Post-CRT values are 3 months after implantation of a biventricular pacemaker.  
 
 
Positive Control Group 
Table 4.2 reports the mean dyssynchrony, echocardiographic, and clinical 
characteristics of the positive control group both before and 3 months after CRT. Patients 
showed a significant (p<0.05) decline in LV end-systolic volume, LV end-diastolic 
volume, and NYHA functional class. Patients also showed a significant (p<0.05) increase 
in LV ejection fraction and quality of life. The mean mitral regurgitation decreased, but 
the decline was not significant. Similarly, the mean six-minute hall walk distance 
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increased but was not significant. 
Diastolic XCD was the only dyssynchrony parameter which showed a significant 
reduction (56%) from baseline to 3 months after biventricular pacemaker implantation. 
Nine, 7 and 8 of the 11 positive controls showed a decrease in whole-cycle, systolic and 
diastolic XCD, respectively, 3 months after CRT compared with only 3, 3, and 5 for 
SLD, MaxDiff and Ts-SD, respectively. Figure 4.2 shows an example of a representative 








Figures 4.3 and 4.4 show values of each dyssynchrony parameter for all the 
positive controls (both before and 3 months after CRT). Four, 6, and 11 of the 11 positive 
controls showed dyssynchrony according to published threshold values (reported in table 
4.1) for SLD, MaxDiff and Ts-SD, respectively. Eleven, 8, and 10 of the 11 positive 









Figure 4.4: Most patients show a reduction in XCD 3 months after CRT. 
 
 
Discrimination Between Positive and Negative Control Groups 
All the cross-correlation delay parameters and Ts-SD showed a significant 
difference between the positive and negative control groups (p<0.01 for all comparisons). 
SLD and MaxDiff did not show a significant difference between the positive and 
negative control groups (p=0.930 and p=0.091, respectively). Figures 4.5 and 4.6 show 
values of each dyssynchrony parameter for all the positive and negative control subjects 
along with threshold values used to diagnose dyssynchrony.  
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Figure 4.5: Time-to-peak parameters show poor discrimination between the positive 
and negative control groups. 
 49
 
Figure 4.6: XCD parameters show excellent discrimination between the positive and 
negative control groups. 
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Figure 4.7: XCD parameters show significant discrimination by ROC analysis. 
 
 
Figure 4.7 shows the ROC curves for each dyssynchrony parameter. All the cross-
correlation delay parameters demonstrated significant discrimination between the positive 
and negative control groups (all p<0.01, Table 4.3). Ts-SD was the only time-to-peak 
parameter which showed significant discrimination between positive and negative 
controls (p<0.01). Whole-cycle XCD had an area under the ROC curve that was 
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significantly greater than SLD (p<0.001) and MaxDiff (p=0.017). Systolic-XCD had an 
area under the ROC curve that was significantly greater than SLD (p=0.044). Diastolic- 
XCD had an area under the ROC curve that was significantly greater than SLD (p=0.001) 
and MaxDiff (p=0.042). ROC analysis determined that a threshold XCD of 25ms had the 
highest sensitivity and specificity of all dyssynchrony parameters (100 and 100%, 
respectively) (Table 4.3).  
 
 
Table 4-3: ROC comparison of dyssynchrony parameters. 
Variable 
 







SLD 0.55 (0.30, 0.79) 0.127 0.712 36 % 58 % 
MaxDiff  0.74 (0.52, 0.95) 0.111 0.056 55 % 50 % 
Ts-SD  0.98 (0.93, 1.03) 0.027 <0.001 100 % 42 % 
Whole-XCD  1.00 (1.00, 1.00)a,b <0.001 <0.001 100 % 100 % 
Systolic-XCD 0.864 (0.71, 1.01)a 0.076 0.003 73 % 75 % 
Diastolic-
XCD  0.955 (0.87, 1.04)
a,b 0.042 <0.001 91 % 92 % 
*Asymptotic 95% confidence interval given in parentheses. †Under the nonparametric assumption.
hypothesis: area under the ROC curve = 0.5 (no discriminatory value). §For discriminating between posit




Quantification of LV dyssynchrony using tissue Doppler imaging (TDI) may 
improve selection of patients who will benefit from cardiac resynchronization therapy.7 
However, most TDI-based dyssynchrony parameters are quantitatively simplistic and rely 
on a “time-to-peak” analysis that utilizes only one of approximately 140 data points of 
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the myocardial velocity curve collected for each heart beat. Based on this limitation, we 
developed 3 new dyssynchrony parameters that utilize all velocity data from 3 
consecutive beats (~420 points). XCD quantifies dyssynchrony throughout the cardiac 
cycle. XCD performed better than published dyssynchrony parameters in: 1) 
demonstrating minimal dyssynchrony in normal negative control subjects, 2) 
discriminating between positive and negative control subjects. 
 
Dyssynchrony in Normal Subjects 
SLD, MaxDiff and Ts-SD showed dyssynchrony in 42, 50 and 58% of negative 
controls, respectively. Given that many studies have suggested a need to expand CRT 
selection criteria to include TDI assessment of LV dyssynchrony7, this number of false 
positives is far from ideal. In contrast, whole-cycle XCD showed dyssynchrony in 0 of 
the 12 negative controls. 
Three studies have quantified dyssynchrony in normal subjects for comparison to 
our results: 1) Yu et al reported a mean Ts-SD of 17±8ms in 88 normal controls6, 2) 
Lafitte et al reported a mean Ts-SD of 16±9ms in 50 normal controls37, and 3) Poerner et 
al reported a standard deviation of 40±27ms in 47 normal controls.56 Note that Poerner et 
al calculated the standard deviation of the 12 segments (including the apex) visible on 2- 
and 4-chamber apical views, which differs slightly from Ts-SD. The mean level of Ts-SD 
in our 12 negative controls was 28±16ms, which falls between the results of these 
previous studies. SLD and MaxDiff have not been measured in normal controls for 
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comparison to our results. 
 
Discrimination Between Positive and Negative Control Groups 
Our results suggest that XCD and Ts-SD can differentiate positive control 
subjects (patients with known dyssynchrony) from negative control subjects (patients 
with no dyssynchrony) more accurately than SLD and MaxDiff. This is consistent with 2 
previous studies that showed Ts-SD was superior to SLD by ROC analysis.35, 57 However, 
the published threshold value for Ts-SD of 34.4ms36 to diagnose dyssynchrony resulted 
in a specificity of only 50%. XCD discriminated between the positive and negative 
control groups with a sensitivity and specificity of 100%. 
Two studies have compared dyssynchrony parameters with a ROC analysis.35, 36 
Both reported Ts-SD having an area under the ROC curve similar to that seen in our 
study (0.96 versus 0.94 and 0.90). Yu et al reported an area under the ROC curve for 
SLD of 0.8035, which is somewhat higher than the value of 0.55 in our study. Future 
studies will be needed to investigate this discrepancy. 
 
Dyssynchrony in Responders to Cardiac Resynchronization Therapy 
Diastolic XCD was the only parameter which decreased after 3 months of 
biventricular pacing within our group of 11 responders to CRT. Previous studies have 
shown a decline in SLD8, 9, MaxDiff34, and Ts-SD19, 20 after CRT. However, a recent 
study reported results similar to ours, with no reduction in Ts-SD following CRT in a 
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group of responders.58 This highlights a problem with current dyssynchrony parameters – 
many are highly non-specific for assessing dyssynchrony and results are not reproducible 
between centers. 
It is important to note that whole-cycle XCD also declined in 9 out of the 11 
positive controls 3 months after CRT. However, one patient had an increase in whole-
cycle XCD from 51 ms to 436 ms, which caused the reduction to be non-significant (p = 
0.44). The high whole-cycle XCD for this patient 3 months after CRT was likely due to a 
failure of cross-correlation analysis (Figures 4.8 and 4.9). The peak correlations for each 
apical view are shown as red circles. The peak correlation between the apical 2-chamber 
view basal anterior and inferior wall velocity curves occurred at a time delay nearly equal 
to half of the R-R interval (the maximum possible delay) and had a low correlation value 
(0.33). The actual delay may have been at the location of the red arrow. Suggestions to 
improve upon this problem are discussed in Chapter 7. Exclusion of this patient shows a 
significant reduction in whole-cycle XCD 3 months after CRT (p = 0.02). 
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Figure 4.8: Whole-cycle XCD may have been calculated erroneously in this patient 3 




Figure 4.9: Velocity curves used to calculate the cross-correlations in Figure 4.8. 
 
Advantages of XCD 
It is important to note that the myocardial velocity curves used to calculate all 
dyssynchrony parameters in this study were taken from identical regions of interest and 
the same heart beats. The difference between the dyssynchrony parameters can be 
attributed to a difference in the post-processing of velocity curves after placement of the 
regions of interest. Therefore, our results suggest that XCD is a more robust processing 
technique to identify dyssynchrony between two myocardial velocity curves. 
Whole-cycle XCD does not require identification of systole or manual selection 
of peak velocities. Most existing TDI dyssynchrony parameters require identification of 
systole so that the peak systolic velocity can be located and not confused with the 
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isovolumic contraction peak. Systole is typically identified by collecting pulsed Doppler 
of the aortic outflow tract or M-mode through the aortic valve.36 However, these 
measurements of aortic valve opening and closure are collected at different times (and 
potentially different heart rates and loading conditions) from when the TDI data is 
collected so that the marking of systole adds a source of potential error to the 
quantification of dyssynchrony. In addition to this, clinicians typically select the systolic 
peaks manually to calculate dyssynchrony parameters, adding yet another source of 
potential error. Whole-cycle XCD eliminates both of these sources of error, and its 
calculation is fully automatable and could be easily incorporated into any TDI post-
processing software.  
All three of the XC delay parameters can be calculated from any velocity curves 
from the 6 basal segments of the LV and are not specific to the Vivid 7 GE ultrasound 
system used in this study. Calculation of XCD adds less than 1 minute to the post-
processing time required to calculate existing TDI dyssynchrony parameters. 
We focused on global dyssynchrony in this study. However, our methodology is 
easily translated into assessment of regional dyssynchrony to aid in determining the area 
of latest activation and assist in optimal lead placement for CRT. The methodology can 
be used to calculate a temporal delay between any two waveforms, and could also be 
applied to strain, strain rate, or displacement curves.  
We used normalized cross-correlation analysis to calculate a temporal delay 
between velocity curves as a measure of dyssynchrony. However, cross-correlation 
methodology can also be used to derive a correlation value at that temporal delay. The 
 58
correlation value is a measure of the similarity in shape between the two velocity curves, 
and this value could prove useful in future studies. For example, in the current study, the 
positive control group showed a significant difference in the correlation value when 
compared to the negative controls (p<0.0001). Further studies are needed to elicit the 
utility of the normalized correlation value. 
 
Study Limitations 
The positive controls were retrospectively identified from a database of patients 
who received CRT at a single center. While retrospective analysis is not ideal, this study 
serves the purpose to introduce the XCD parameters and demonstrate their potential. 
Prospective, multi-center studies are needed to further explore the utility of XCD in 
diagnosing dyssynchrony. 
As opposed to several previous studies that have introduced new techniques to 
quantify LV dyssynchrony, we chose not to base the initial evaluation of XCD 
parameters on their ability to discriminate responders from non-responders. There are 
many causes for a non-response to CRT in addition to the absence of baseline 
dyssynchrony.7 We strongly believe that in order to rigorously investigate the phenomena 
of a “non-response to CRT”, we must be sure that our measurement of baseline 
dyssynchrony does in fact quantify dyssynchrony as accurately as possible. Only then 
will we be able to improve selection criteria by identification of all factors that affect the 
outcome of CRT. Therefore, we felt it was important to establish the rigor of the XCD 
parameters in a positive and negative control study prior to exploring their ability to 
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discriminate responders from non-responders. 
We did not use age-matched controls in our study. However, this is not a case-
control study. We wanted the negative controls to be entirely free of dyssynchrony. Since 
LV dyssynchrony may increase with age56, the young negative controls in our study are 
less likely to have dyssynchrony than a group of age-matched controls.  
This study is limited by a small sample size. However, the sample size was large 
enough to show statistical differences between XCD and the other dyssynchrony 
parameters. Future studies with larger sample sizes will be required to further 
characterize the utility of the XCD parameters. 
Temporal delay calculated from a normalized cross-correlation analysis may not 
be accurate when the correlation value is low (i.e. less than 0.5, for example). This issue 
may become important when using XCD to discriminate responders to CRT from non-
responders. However, XCD worked very well in the subjects in this study, and a larger 
sample size would be needed to investigate this potential limitation. 
The effect of frame rate on the calculation of XCD was not investigated in this 
study and is a potentially important issue to investigate in the future. 
 
Conclusions 
Cross-correlation delay (XCD) is a new, highly automatable method for 
quantifying left ventricular dyssynchrony that is superior to existing parameters at 
discriminating patients with known dyssynchrony from those with normal LV function. 
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In the patients we examined, a threshold whole-cycle XCD of 25 ms discriminated 
positive and negative control groups with 100% accuracy.   
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CHAPTER 5  
AIM 3: EVALUATE THE ABILITY OF XCD TO DIAGNOSE 
ACUTE “PACING-INDUCED DYSSYNCHRONY” 
 
Introduction 
Accurate diagnosis of mechanical dyssynchrony in the heart is becoming 
increasingly important for two reasons. First, the presence of mechanical dyssynchrony 
has been shown to be a predictor of cardiac events in heart failure patients33. Second, 
dyssynchrony can be treated successfully with cardiac resynchronization therapy (CRT) 
utilizing biventricular pacemaker implantation5.  
The results of Chapter 4 demonstrated that the XC delay parameters had a 
superior ability to diagnose dyssynchrony in patients with heart failure compared to 
normal, healthy controls. This chapter will further investigate the ability of XC delays to 
quantify mechanical dyssynchrony in the heart. We will utilize a model of dyssynchrony 
to verify whether XC delays are able to diagnose dyssynchrony. 
A recent study showed that the most commonly used dyssynchrony parameters 
agree on the diagnosis of dyssynchrony only half the time37. Thus, while many 
parameters to quantify dyssynchrony have been proposed, no single methodology has 
emerged as a standard. This lack of consensus on a single parameter may be due to two 
limitations of current parameters.  
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First, many dyssynchrony parameters are based on an approach that examines the 
“time-to-peak” systolic velocity of a ventricular wall using tissue Doppler imaging 
(TDI)7. This analysis assumes that the peak systolic velocity is the most clinically 
important component criterion of ventricular synchrony. Furthermore, it is quantitatively 
simplistic in that it utilizes only 1 data point from the 140 points typically collected per 
heart beat. This peak may also be difficult to identify. For example, it is often located 
near the isovolumic contraction peak. 
To overcome the first limitation, we developed a new mathematical method to 
calculate a temporal delay between two myocardial velocity curves. Our method utilizes 
a cross-correlation function to quantify systolic, diastolic or whole-cycle cross-correlation 
delay (XCD) using TDI data collected throughout the cardiac cycle. By using all data 
points on the velocity curves, XCD does not rely on peak values like “time-to-peak” 
analyses. 
The second limitation of current dyssynchrony parameters is that they were all 
developed solely to identify patients who will benefit from CRT7. No parameter has been 
evaluated in a model system of dyssynchrony such as “pacing-induced dyssynchrony.” 
Thus, it is unclear whether existing dyssynchrony parameters are in fact quantifying 
dyssynchrony accurately. Pacing from the right ventricular apex (RVA) creates a model 
of dyssynchrony59 that can be compared to synchronous, atrial pacing at the same rate as 
a negative control. This has been performed in dogs60, 61 and in humans62. Based on 
similarities between electrocardiogram patterns in RVA pacing and left bundle branch 
block, this model is often referred to as “pacing-induced left bundle branch block” or 
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“experimental left bundle branch block”60, 62, 63. 
To overcome the second limitation, we evaluated the ability of the three XCD 
parameters to identify pacing-induced dyssynchrony in patients who received catheter 
ablation for non-preexcited supraventricular tachycardia. We compared the XCD 
parameters to three standard dyssynchrony parameters. We hypothesized that XCD 
parameters would perform better at diagnosing ventricular dyssynchrony than existing 




Inclusion criteria were referral for catheter ablation of non-preexcited reentrant 
supraventricular tachycardia (i.e., atrioventricular nodal re-entrant tachycardia or 
atrioventricular re-entrant tachycardia) and normal cardiac structure and function 
documented on 2-dimensional echocardiography. Patients were excluded if they 
exhibited manifest preexcitation on baseline sinus 12-lead electrocardiogram. Fourteen 
patients (age 12.9 + 3.6 years, 9 male) fit the criteria and were included. The study was 
approved by the Children’s Healthcare of Atlanta institutional review board and all 
subjects gave informed consent prior to enrollment. 
 
Electrophysiology 
Studies and ablations were performed with the patient under general anesthesia 
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with continuous propofol infusion, which is standard at our institution. All cardiac 
medications were discontinued 5 days before the procedure. Quadrapolar catheters were 
placed in the RVA, right atrial appendage and adjacent to the His bundle, and a decapolar 
catheter was advanced into the coronary sinus. Tachycardia mechanism was confirmed 
with standard electrophysiologic testing.  
The decision to ablate the arrhythmia substrate was based upon clinical 
indications. Catheter ablation was performed either with radiofrequency energy or 
cryotherapy at the discretion of the attending electrophysiologist. Subsequent 
electrophysiologic testing confirmed elimination of tachycardia substrate in all patients.  
The pacing and TDI data collection were performed during the post-ablation 
waiting interval so as not to increase the duration of the patient’s procedure. Cardiac 
pacing was performed at identical rates with the following configurations: atrial pacing 
from the right atrial appendage (AAI) and ventricular VVI pacing from the right 
ventricular apex (RVA). The sequence of pacing modes was random for each patient and 
a washout time of 3 minutes was used between pacing modes. QRS morphology was 
used to exclude fusion and capture beats from analysis. The pacing rate was set to 25% 
over normal sinus rhythm to a minimum of 100 beats per minute to ensure intrinsic 
ventricular conduction did not occur.  
 
Echocardiographic Acquisition 
Apical 2-, 3- and 4-chamber tissue Doppler color velocity images were collected 
during each pacing mode (AAI and RVA) and during normal sinus rhythm (NSR) with a 
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5MHz GE (Horten, Norway) Vivid 7 system. This enabled evaluation of dyssynchrony 
parameters in a state of dyssynchrony (RVA) compared to normal synchrony (AAI and 
NSR). Patients were paced for at least one minute prior to image acquisition. Tissue 
Doppler was acquired at a minimum frame rate of 140 Hz, and the ventricular walls were 
aligned to within 200 from parallel with the Doppler beam. Pulsed Doppler of the aortic 
outflow tract was acquired during each pacing mode to identify systole for measurement 
of systolic dyssynchrony parameters. A minimum of 3 beats of velocity data were 
collected during a breath-hold. 
 
Tissue Doppler Post-processing 
EchoPAC PC SW post-processing software (version 4.0.3, GE Vingmed, Horten, 
Norway) was used to generate 3-beat average curves of longitudinal velocity versus time 
from the 12 basal and mid-wall segments of the left ventricle. Each velocity curve was 
exported from a stationary 30x6 mm oval region of interest. The curves were processed 
with the default averaging filter (30ms) within the EchoPAC software prior to export. 
Systole was defined using the pulsed Doppler data from the aortic outflow tract so that 
the peak systolic velocities could be identified.  
 
Cross-correlation Analysis 
Prior to cross-correlation processing, the velocity curves were bilinearly 
interpolated so that there was a constant time step between data points for each subject. 
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Cross-correlation post-processing of velocity curves was performed in MatLab 
quantitative analysis software (version 7.10, MathWorks, Inc., Natick, MA). A cross-
correlation function was used to calculate the time delay which resulted in maximum 
correlation between velocity curves from opposing ventricular segments. One velocity 
curve was shifted relative to the other curve, and the cross-correlation value was 
computed for each time shift using a normalized scale. A value of 1 meant the two curves 
were perfectly synchronous in time while a value of –1 meant the two curves were 
dyssynchronous. A value of 1 is achieved when “auto-correlating” a velocity curve with 
itself while a value of –1 is achieved when correlating a velocity curve with its own 
negative. The time shift between the two curves that resulted in the maximum correlation 
value was defined as the cross-correlation delay (XCD) between the two curves.  
Three dyssynchrony parameters were calculated with a cross-correlation function:  
(1) Whole-cycle XCD – The maximum cross-correlation temporal delay between 
myocardial velocity curves from opposing basal sections in apical 2-, 3- and 
4-chamber views. This represents a maximum of three cross-correlation 
temporal delays (one delay between the velocity curves from the two 
opposing basal segments in each of the three apical views).  
(2) Systolic XCD – The maximum cross-correlation temporal delay between the 
systolic portion of the myocardial velocity curves from opposing basal 
sections in apical 2-, 3- and 4-chamber views. Systole was defined to include 
the isovolumic contraction period as mitral valve closure to aortic valve 
closure. 
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(3) Diastolic XCD – Diastolic XCD was calculated similarly to systolic XCD, 
except the diastolic portion of the velocity curve was used. Diastole was 
defined as aortic valve closure to mitral valve closure. 
 
Calculation of Time-to-Peak Dyssynchrony Parameters 
Three time-to-peak dyssynchrony parameters were calculated for comparison to 
the cross-correlation dyssynchrony parameters: 
(1) SLD – Basal septal-to-lateral delay in time-to-peak systolic velocity8 
(2) MaxDiff – maximum difference in time-to-peak systolic velocity between any 
2 of the basal septal, lateral, anterior and inferior left ventricular segments34 
(3) Ts-SD – the standard deviation of times-to-peak systolic velocity in the 12 
basal and mid-wall segments of the left ventricle36 
It is important to note that these time-to-peak dyssynchrony parameters were 
calculated with the same velocity curves from the same regions of interest used in the 
XCD analysis.  
 
Correction for Heart Rate 
To facilitate comparison of dyssynchrony parameters at different heart rates 
(paced heart rates were 25% higher than NSR and heart rates differed significantly 





Statistical calculations were performed in SPSS version 14.0 (SPSS Inc., Chicago, 
IL). A value of p<0.05 was defined as statistically significant. Dyssynchrony parameters 
were compared by their ability to: 
(1) Detect the pacing-induced dyssynchrony caused by RVA pacing: Mean values 
of each parameter for the different pacing modes (NSR, AAI, RVA) were 
compared using a repeated-measures ANOVA with a Huynh-Feldt correction 
followed by a Bonferroni multiple comparison post-hoc test.  
(2) Diagnose dyssynchrony using a numerical threshold: ROC curves were 
generated for each parameter by plotting sensitivity versus 1-specificity for 
multiple threshold values. The area under the ROC curve was used to rank the 
ability of the dyssynchrony parameters to discriminate between AAI pacing 
(no dyssynchrony) and RVA pacing (dyssynchrony). Threshold values to 
diagnose dyssynchrony were then determined for each parameter by locating 
the point on the ROC curves where sensitivity was equal to specificity34. 
 
Results 




Table 5-1: Dyssynchrony values for the time-to-peak parameters during each pacing 
mode. 
 SLD MaxDiff Ts-SD 
Patient Number NSR AAI RVA NSR AAI RVA NSR AAI RVA 
1 24 34 110 23 34 118 27 30 89 
2 14 18 30 17 18 92 6 11 51 
3 107 74 39 109 90 138 60 38 86 
4 96 132 9 96 152 172 74 62 68 
5 10 21 87 61 73 98 94 43 47 
6 66 111 90 138 115 92 63 48 53 
7 156 70 77 176 126 90 62 54 88 
8 97 91 126 131 99 178 72 57 86 
9 54 113 18 54 120 209 46 59 65 
10 104 127 113 112 127 153 51 73 96 
11 69 73 96 122 101 96 56 64 42 
12 29 22 158 29 22 164 53 25 84 
13 119 110 0 222 110 6 80 72 101 
14 18 23 145 21 39 146 16 25 76 




Table 5-2: Dyssynchrony values for the XCD parameters during each pacing mode. 
 Whole-XCD Systolic-XCD Diastolic-XCD 
Patient Number NSR AAI RVA NSR AAI RVA NSR AAI RVA 
1 6 7 7 58 41 136 6 14 7 
2 14 17 87 7 17 122 15 26 19 
3 8 17 9 99 109 85 8 17 9 
4 8 13 9 55 78 0 8 0 9 
5 10 11 0 20 84 137 10 0 0 
6 7 9 9 103 82 127 7 9 0 
7 8 17 9 62 69 120 8 17 9 
8 14 10 29 78 87 155 7 10 0 
9 9 18 11 9 166 190 11 18 11 
10 7 16 33 57 25 190 7 8 0 
11 71 98 224 85 71 128 71 98 150 
12 19 20 26 38 10 180 19 20 26 
13 13 16 32 88 40 199 14 16 32 
14 0 22 36 20 51 7 0 22 14 
All values are dyssynchrony in milliseconds. AAI = right atrial appendage pacing; NSR = normal sinus 
rhythm with no pacing; RVA = right ventricular apex pacing; XCD = cross-correlation delay. 
 




Figure 5.1 shows velocity curves from the septal and lateral wall of a 
representative patient. The systolic and diastolic cross-correlation plots for this patient are 
also shown to illustrate how the XCD parameters were calculated. This patient showed a 






Figure 5.2: Systolic XCD is the only parameter that is increased due to RVA pacing 
compared to AAI and NSR. 
 
 
Table 5-3: Dyssynchrony parameters for each pacing mode. 
Parameter NSR AAI RVA p* 
Dyssynchrony Parameters     
SLD 69 ± 46 73 ± 43 78 ± 51 0.794 
MaxDiff 94 ± 63 87 ± 43 125 ± 51 0.160 
Ts-SD 54 ± 24 47 ± 19 74 ± 19 † 0.002 
Whole-XCD 14 ± 17 21 ± 23 37 ± 58 0.079 
Systolic-XCD 56 ± 33 66 ± 41 127 ± 62 †,§ 0.001 
Diastolic-XCD 14 ± 17 20 ± 24 20 ± 38 0.285 
QRS Duration (ms) 80 ± 15 78 ± 16 140 ± 15†,§ <0.001 
Heart Rate (bpm) 86 ± 19 109 ± 15§ 109 ± 15§ <0.001 
Data are mean ± SD. n = 14 for all pacing modes. *repeated-measures ANOVA for comparing the mean 
values between pacing modes, †p<0.05 versus AAI by Bonferroni post-hoc multiple comparison. §p<0.05 
versus NSR by Bonferroni post-hoc multiple comparison. 
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AAI versus NSR 
No parameter showed a difference in dyssynchrony between AAI and NSR 
(Figure 5.2 and Table 5.3). Thus, acute atrial pacing did not change the level of 
dyssynchrony from that present at baseline during NSR.  
 
Systolic Dyssynchrony 
AAI versus RVA 
Acute RVA pacing created systolic dyssynchrony. Ts-SD and systolic XCD 
showed a significant increase from AAI to RVA pacing (p=0.003 and p=0.005, 
respectively) (Figure 5.2). SLD and MaxDiff were not significantly different between the 
AAI and RVA pacing modes. Systolic XCD had the greatest percent increase from AAI 
to RVA pacing (91% increase versus 57% for Ts-SD).  
NSR versus RVA 
Systolic XCD was the only parameter that was significantly different between 
NSR and RVA pacing modes (Figure 5.2 and Table 5.3). 
 
Diastolic Dyssynchrony 
Acute RVA pacing did not create diastolic dyssynchrony. Diastolic XCD did not 




Whole-cycle XCD was not significantly different between any of the pacing 
modes (p = 0.079). 
 
ROC Analysis 
Ts-SD and systolic XCD were the only dyssynchrony parameters that showed 
significant discrimination between AAI and RVA pacing modes (Table 5.4 and Figure 
5.3). Systolic XCD had an area under the ROC curve that was significantly greater than 
SLD. Systolic XCD had the highest sensitivity and specificity of 79% to diagnose 
dyssynchrony, compared with 57%, 57% and 71% SLD, MaxDiff and Ts-SD, 
respectively (Table 5.4). 
 
 
Table 5-4: ROC comparison of dyssynchrony parameters. 







SLD 0.783 0.53 (0.31, 0.75) 0.11 82 ms 57% 57% 
MaxDiff 0.081 0.69 (0.49, 0.90) 0.10 106 ms 57% 57% 
Ts-SD 0.004 0.82 (0.67, 0.98) 0.08 60 ms 71% 71% 
Whole-cycle 
XCD 
0.854 0.52 (0.28, 0.76) 0.12 17 ms 50% 57% 
Systolic XCD 0.006 0.81 (0.61, 1.00) 0.10 86 ms 79% 79% 
Diastolic XCD 0.112 0.39 (0.17, 0.61) 0.11 12 ms 36% 36% 
*Null hypothesis: area under the ROC curve = 0.5 (no discriminatory value). †Asymptotic 95% confidence 
interval given in parentheses. ‡Under the nonparametric assumption. §For diagnosing dyssynchrony due to 








We sought to develop and test a new parameter to quantify dyssynchrony in the 
heart that does not rely on identification of peak myocardial velocities. We developed 
three parameters which all utilize a cross-correlation function and calculated the systolic, 
diastolic or whole-cycle dyssynchrony between velocity curves from opposing 
ventricular walls. We demonstrated two important results: 
(1) Cross-correlation delay analysis of myocardial velocity curves is superior to 
existing parameters for quantitatively assessing dyssynchrony in this model of 
pacing-induced dyssynchrony in the human heart. Systolic XCD showed the 
largest increase from normal synchrony (AAI) to pacing-induced 
dyssynchrony (RVA) and had the highest sensitivity and specificity for 
discriminating between AAI and RVA. 
(2) Acute right ventricular apex pacing creates systolic dyssynchrony with 
preserved diastolic synchrony. 
 
Dyssynchrony Assessment to Identify Responders to CRT 
The most widely-used application of dyssynchrony parameters is selection of 
patients who respond favorably to CRT7. Identification of these “responders” to CRT is 
important, as one-third of patients selected for CRT show no improvement5. Several 
studies have shown that responders to CRT have a high degree of mechanical 
dyssynchrony while non-responders do not7.  
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However, the discrimination of responders from non-responders is complicated by 
additional factors such as heart failure etiology, scar burden, lead placement, gender and 
mitral regurgitation64, 65. Accurate quantification of dyssynchrony is essential for 
quantifying the influence of these additional factors in predicting response to CRT. We 
developed a new, more quantitatively sophisticated dyssynchrony parameter and showed 
its superiority to existing parameters in diagnosing dyssynchrony in a pacing-induced 
model of dyssynchrony.  
 
Pacing-induced Dyssynchrony 
Patients with non-preexcited supraventricular tachycardia represent a unique 
population with structurally normal hearts in which it is possible to conduct well-
controlled acute dyssynchrony experiments in humans. We acutely paced the right 
ventricular apex at rates slightly above the intrinsic heart rates in order to create a 
“pacing-induced dyssynchrony.” 
Wyman et al used tagged MRI to prove that RVA pacing in a canine model 
creates a mechanical dyssynchrony in the left ventricle59. The authors determined that the 
inter-ventricular septum is rapidly activated during RVA pacing, perhaps due to limited, 
local activation of the Purkinje system. Purkinje activation did not spread beyond the 
septum, as the rapid septal activation was followed by a slower spread of mechanical 
activation towards the left ventricular free wall at a rate similar to values reported for 
electrical conduction through the myocardium59. This provides evidence that RVA pacing 
creates a dyssynchrony that should be quantifiable using standard echocardiographic 
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dyssynchrony parameters. We documented this dyssynchrony in RVA pacing using 
existing parameters and our new XCD parameters. Systolic XCD showed better 
discrimination between synchronous and dyssynchronous activation than the standard 
dyssynchrony parameters. 
 
Diastolic Function During Ventricular Pacing  
Ventricular pacing acutely impairs diastolic function by increasing the time 
constant of relaxation,66-68 decreasing the peak lengthening rate68 and decreasing peak 
negative dP/dt.68, 69 Thus, one might hypothesize that acute RVA pacing would cause 
diastolic dyssynchrony. However, our results show that acute RVA pacing does not affect 
diastolic synchrony.  
Our results can be explained by a discussion of the predominant factors which 
control relaxation in the heart. Diastolic relaxation is controlled both by the sensitivity of 
the contractile system to the prevailing load (load dependence) and the decaying 
activation (inactivation dependence).70 Several energy-dependent processes (such as the 
detachment of actin from myosin and sequestering of calcium into the sarcoplasmic 
reticulum) determine the inactivation dependence of the ventricle.71 This inactivation-
dependent control mechanism modulates the load-dependent control, which is dominant 
during early diastolic relaxation.72 This early-diastolic load dependence enables the fibers 
to elongate instantaneously in unison during early diastole despite potentially 
inhomogeneous, or dyssynchronous, activation.72 Thus, dyssynchronous activation of 
healthy myocardium where the load dependence of relaxation is maintained leads to 
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systolic dyssynchrony with preserved diastolic synchrony. 
  
Diastolic Dyssynchrony 
 While most studies on dyssynchrony have focused on systole, diastolic 
dyssynchrony is more frequent than systolic dyssynchrony in dilated cardiomyopathy.73, 
74 In addition, diastolic dyssynchrony has been reported in other cardiovascular diseases 
such as hypertrophic cardiomyopathy.75 Thus, evaluation of diastolic synchrony may be 
important, and few studies have investigated this phenomenon.  
This is the first study to demonstrate the effect of acute RVA pacing on diastolic 
synchrony in structurally normal human hearts. We demonstrated that acute RVA pacing 
does not affect diastolic synchrony despite the large increase in systolic dyssynchrony. 
Our results suggest that systolic and diastolic dyssynchrony develop through separate 
mechanisms. This finding is corroborated by a recent study on 373 patients with 
congestive heart failure in which isolated diastolic dyssynchrony was present in 18% of 
patients and isolated systolic dyssynchrony was present in 30% of patients.76 Other 
studies have also shown a lack of correlation between systolic and diastolic 
dyssynchrony.77 Thus, systolic and diastolic dyssynchrony do not appear to be tightly 
coupled and potentially develop through separate mechanisms. 
In contrast to systolic dyssynchrony, diastolic dyssynchrony in heart failure may 
develop over a longer duration. A recent study by Kang et al compared patients with 
acquired LBBB to patients with RV pacemakers and normal function.77 The RV-paced 
patients had a low amount of diastolic dyssynchrony that was comparable to that of the 
 79
patients with acquired LBBB and normal EF. However, patients with LBBB and low EF 
(<35%) had nearly three times the level of diastolic dyssynchrony compared to patients 
with LBBB and normal EF. The authors concluded that conduction system disease alone 
cannot induce diastolic dyssynchrony, and pathology of the myocardium may be the 
cause of both diastolic dyssynchrony and LV systolic dysfunction.77 Our results further 
support the hypothesis that conduction system disease alone cannot induce diastolic 
dyssynchrony by showing that diastolic dyssynchrony does not develop during acute 
dyssynchronous activation of the LV (which is a model for LBBB conduction system 
disease). 
Dyssynchronous electrical activation of the LV leads to pathological changes in 
the myocardium,78 which may be the cause of diastolic dyssynchrony. Dyssynchronous 
activation induces hypertrophy of the LV wall in late activated regions both in dogs79 and 
in humans with congenital complete heart block and pacing-induced dyssynchrony.80 LV 
mass index correlates with diastolic dyssynchrony in patients with heart failure and 
normal ejection fraction.74 Therefore, the hypertrophy due to long-term dyssynchronous 
activation in the LV may play an important role in causing diastolic dyssynchrony in 
heart failure. 
The process of calcium binding and uptake is also disturbed in the failing 
myocardium.81, 82 This may alter the load sensitivity following the isovolumic relaxation 
period since efficient calcium sequestering in the sarcoplasmic reticulum is required to 
generate the early diastolic load dependence.72 Thus, regional inhomogeneities in the 





There are two studies that conflict with our results. First, Betocchi et al found that 
acute ventricular pacing increases diastolic dyssynchrony relative to atrial pacing in 
patients with coronary artery disease.83 However, in this patient group, early onset of 
lengthening may occur in hypoxic muscle supplied by partially occluded coronary 
arteries.84, 85 In addition, hypoxia suppresses the load dependence of relaxation,72 
suggesting that patients with coronary artery disease may have a different response to 
acute pacing relative to the healthy patients in our study.  
Aoyagi et al reported that diastolic dyssynchrony increased from 12 ± 4 during 
right atrial pacing to 27 ± 6 during RVA sequential pacing in 7 open-chest dogs.66 This 
study only examined dyssynchrony between 3 segments on the anterior wall as opposed 
to our study in which we examined dyssynchrony from all 6 walls of the LV. Also, we 
quantified dyssynchrony using cross-correlation methodology which is potentially more 
accurate in identifying dyssynchrony than time to peak analysis86 such as that employed 
by Aoyagi et al. 
 
Systolic Dyssynchrony 
Systolic dyssynchrony appears to be an acute effect of dyssynchronous activation. 
Our study and previous studies59, 87, 88 have shown that systolic dyssynchrony is acutely 
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created by RVA pacing. Conduction system disease in patients with congestive heart 
failure can also lead to systolic dyssynchrony and worsened LV function which can be 
treated with cardiac resynchronization therapy (CRT) utilizing biventricular pacemakers.7 
CRT acutely reduces systolic dyssynchrony,89 and the reduction can be reversed 
immediately when the pacemaker is turned off.9 Thus, LV systolic dyssynchrony is an 
acutely-induced, reversible consequence of dyssynchronous activation.  
 
ROC Thresholds Relative to Previously Determined Thresholds for SLD, MaxDiff 
and Ts-SD 
We defined threshold levels of dyssynchrony to discriminate between AAI pacing 
and RVA pacing at the same heart rate. Our results are different from published threshold 
values for SLD, MaxDiff and Ts-SD in adults (82 versus 60ms8, 106 versus 65ms34, and 
60 versus 34.4ms36, respectively). This difference may in part be due to heart rate as we 
normalized by the square root of the R-R interval while studies in adults typically do not 
do this (un-normalized threshold values would be approximately 67, 86, and 49 ms for 
SLD, MaxDiff and Ts-SD, respectively). However, heart rates in adults are typically 
close to 60 bpm while heart rates in the children in this study ranged from 60 to nearly 
150 bpm, so we thought it was important to normalize. This is the first study to determine 




CRT in Pediatrics 
CRT is now being used in a limited number of pediatric patients with dilated 
cardiomyopathy90. While CRT has shown extremely promising results in adults, the 
translation of this success into the pediatric population is complicated by the 
heterogeneity of the underlying cardiac defects. To date, there is little or no evidence-
based medicine to prove the benefit of CRT in pediatric patients. Existing evidence is in 
the form of case reports and case series90 with no prospective multi-center trials 
completed or ongoing.  
A critical first step in translation of CRT into pediatrics is identifying a population 
of patients who have a high likelihood of responding to the treatment. The current study 
provides a noninvasive measure to diagnose dyssynchrony in pediatric patients that is 
superior to similar measures used in adults. This may help identify pediatric patients who 
will respond favorably to CRT.  
The absence of diastolic dyssynchrony in this acute pacing model also has 
implications for the young patient who requires life-long ventricular pacing. If diastolic 
dyssynchrony is indeed a long-term sequela of dyssynchronous ventricular activation, 
then young patients who receive life-long RVA pacing may develop a “pacing-induced 
diastolic dyssynchrony.” Further investigation into this area may have implications for 





The patients in this study underwent an invasive cardiac procedure involving 
catheter ablation, which may have an unknown effect on structure and/or function. 
However, we documented normal cardiac structure and function with 2-dimensional 
echocardiography and 12-lead electrocardiography following ablation of the arrhythmia 
substrate. The patients also served as their own controls, which should minimize any 
effect the procedure had on the data. 
We paced patients for 1 minute before acquiring tissue Doppler images to assess 
dyssynchrony. We did not pace patients for a longer duration in order to minimize the 
length of the catheterization procedure. Diastolic dyssynchrony may develop after a 
longer duration of pacing. However, multiple studies have documented the acute decline 
in systolic and diastolic function due to RVA pacing after only 15-30 seconds.66, 68 Thus, 
we felt it was important to also document the effect of ventricular pacing on diastolic 
dyssynchrony after a similar duration of 1 minute prior to exploring the longer-term 
effects. 
This study is limited by a small sample size (14 patients). However, the sample 
size was large enough to show statistical differences in systolic dyssynchrony between 
pacing modes. 
RVA pacing was performed in VVI mode, which de-synchronizes the atria and 
ventricles. We chose VVI over AV synchronous pacing to ensure that conduction from 
the atria through the AV node did not occur during RVA pacing. This atrio-ventricular 
de-synchronization may affect LV diastolic synchrony. However, we found no difference 
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in LV diastolic synchrony between AAI and VVI-RVA pacing modes. Thus, if atrio-
ventricular de-synchronization does affect diastolic synchrony, the effect is very small. 
 
Conclusions 
We developed a new parameter (XCD), which utilizes a cross-correlation function 
to analyze data from the entire cardiac cycle for quantifying systolic, diastolic or whole-
cycle mechanical dyssynchrony in the heart. We compared XCD to existing 
dyssynchrony parameters in a model system of pacing-induced dyssynchrony in 
structurally normal human pediatric hearts. Our results demonstrated that XCD analysis 
of myocardial velocity curves is a more robust method for quantifying dyssynchrony than 
“time-to-peak” analyses used in the calculation of existing parameters. Using both our 
new parameters and existing dyssynchrony parameters, we showed that acute right 
ventricular apex pacing creates systolic dyssynchrony with preserved diastolic synchrony.  
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CHAPTER 6  
AIM 4: DEVELOP AND EVALUATE A NEW METHOD FOR 
QUANTIFYING LEFT VENTRICULAR INTERNAL FLOW FROM 
STANDARD CINE CARDIAC MAGNETIC RESONANCE IMAGES 
 
Introduction 
Specific Aim 4 focuses on achieving the 2nd objective of this dissertation (develop 
a non-invasive method to quantify internal flow within the LV as a measure of 
dyssynchrony). The development and validation of cross-correlation methodology in 
Specific Aims 1-3 focused on improving the quantification of dyssynchrony using tissue 
Doppler data that is routinely available. However, Aim 4 focuses on a different approach 
to quantification of dyssynchrony based on the dyssynchrony in blood flow.  
The presence of left ventricular (LV) dyssynchrony increases mortality91, and 
dyssynchrony can be effectively treated with cardiac resynchronization therapy (CRT) 
utilizing a biventricular pacemaker5. Surface electrocardiogram QRS duration remains 
the only accepted clinical measure of LV dyssynchrony for identifying patients who need 
CRT, but sensitivity92 and specificity7 are low (~50-60%). Thus, better methods to 
quantify LV dyssynchrony are needed. 
Mechanical dyssynchrony creates abnormal displacement of blood within the LV, 
between early-activated regions and late-activated regions10, 11. This internal flow, or 
“sloshing,” represents wasted energy due to dyssynchronous motion of the LV walls. 
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Quantification of internal flow may represent a better method to diagnose the presence 
and physiologic severity of dyssynchrony that could be used to identify patients who 
need treatment with CRT.  
LV internal flow has been quantified from regional volume measurements made 
with a conductance catheter11. However, catheter-based quantification of internal flow is 
an invasive and expensive procedure. We hypothesized that: 1) LV internal flow can be 
quantified non-invasively using standard cine cardiac magnetic resonance (CMR) images 
and 2) CMR-based internal flow will be significantly increased in patients undergoing 
CRT compared to healthy, normal controls.  
 
Materials and Methods 
CMR images were obtained from 10 patients (age 64 ± 14 years, 6 Male) being 
evaluated for treatment with CRT. Inclusion criteria were New York Heart Association 
class III or IV heart failure, LV ejection fraction <35%, and QRS >150ms. CMR images 
were also obtained from 10 healthy volunteers (age 30 ± 7 years, 9 Male) with no history 
of cardiac disease, normal 12-lead electrocardiography and normal CMR. The study was 
approved by the institutional review board, and all subjects gave informed consent prior 
to enrollment. 
 
Image Acquisition  
Steady-state free procession short-axis cine images were acquired during 10-15 
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second breath-holds with a 1.5T Philips Intera scanner using a 5-element phased array 
cardiac coil (Philips Medical Systems, Best, Netherlands). Contiguous 8-10mm short axis 
slices were acquired at 20 frames per cardiac cycle. Acquisition parameters were as 
follows: acquired matrix size = 192 x 256, reconstructed matrix size = 256 x 256, field of 
view  = 370 mm, flip angle = 650, TR = 4 msec, and TE = 2 msec. Two-chamber and 
four-chamber SSFP long-axis cine images were also acquired. 
 
Quantification of Internal Flow 
Calculation of internal flow required three main steps: 1) three-dimensional 
reconstruction of the LV cavity from the two-dimensional CMR images (Figure 6.1A), 2) 
segmentation of the LV cavity into regional volumes (Figures 6.1B and 6.2), and 3) 
quantification of internal flow from the regional volume versus time curves. These steps 
are described in separate sections below. 
 
Three-dimensional Reconstruction of the Left Ventricular Cavity 
Image processing was performed in MatLab (version 7.40, The MathWorks, 
Natick, MA). The endocardial surface was detected in each image with a semi-automated 
level set approach93. The short-axis images were registered to the 2-chamber long-axis 
images to correct for differences in the level of the diaphragm during end-expiration 
breath-hold acquisitions. A three-dimensional LV endocardial surface was created from 
the endocardial border points identified on the CMR images (Figure 6.1A). The aortic 
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Figure 6.2: Segmentation of the LV cavity into 16 regional volumes. 
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Segmentation into Regional Volumes 
The three-dimensional LV endocardial surface was divided into 16 wedge-shaped 
regional volumes according to the American Heart Association standardized 
segmentation model for the left ventricle43 (Figures 6.1 and 6.2). This standardized 
segmentation model consists of 6 wedge-shaped 600 regional volumes at the basal and 
mid-wall levels and 4 wedge-shaped 900 regional volumes at the apex. 
A vertical axis from the center of the mitral annulus to the apex was defined on 
both the 2-chamber and 4-chamber long-axis images. The center of the mitral annulus 
was defined as the midpoint of the 2 manually identified leaflet insertion points (shown 
as red circles in Figure 6.2A). To define the apex, a line was drawn from the center of the 
mitral annulus through the center of the bottom 15% of the endocardial border points on 
each long-axis image (shown as a black “+” sign in Figure 6.2A). This line was extended 
beyond the endocardial border and its intersection with the endocardium was defined as 
the apex (shown as a green circle in Figure 6.2A). This vertical axis was defined for each 
time frame in the cardiac cycle. The LV vertical axis was defined as an average of the 2-
chamber and 4-chamber vertical axes for each time frame. The vertical axis was then 
used to define basal, mid-wall, and apical longitudinal locations after excluding the 
outflow tract as shown in Figure 6.2A.  
The anterior right ventricular insertion point was defined on an end-diastolic basal 
short-axis image (Figure 6.2B). A plane passing through this right ventricular insertion 
point and the mean vertical axis (the mean of the vertical axes from each time frame) was 
defined. This plane was rotated 600 around the vertical axis and again rotated 1200 to 
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define the 6 wedge-shaped regional volumes at each of the basal and mid-wall locations. 
The same plane was rotated 150 and 1050 to define the 4 wedge-shaped regional volumes 
at the apex.  
 
Internal Flow Calculation 
The volume of each wedge-shaped region was calculated for each time step to 
generate the 16 regional volume versus time curves. The regional volume curves were 
smoothed with a Gaussian kernel (length = 5, standard deviation = 1). Internal flow was 
calculated from these 16 regional volume curves.  
Internal flow within the LV decreases volume in one region of the ventricle while 
simultaneously increasing volume in an adjacent region. This flow results in no net 
change in the global LV volume. Thus, for each time step in the cardiac cycle, the sum of 
the absolute value of the changes in the regional volumes is not equal to the absolute 
value of the change in the global volume if internal flow has occurred during that time 
step. Therefore, we defined internal flow as11:  
( )












where IF(t) is the volume of internal flow at time t, Vi(t) is the volume of segment i at 
time t, and VLV(t) is the volume of the entire LV at time t: 
( )∑=
i
iLV tVtV )(  (
(6-2) 
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Note that division by 2 in equation (1) accounts for the fact that any blood which 
exits one regional volume must enter another regional volume if it does not leave the LV. 
Internal flow fraction (IFF) was defined as the total internal flow divided by the stroke 
volume. IFF was calculated in systole (IFFsystole), diastole (IFFdiastole) and over the entire 
cardiac cycle (IFFwhole). End-systole and end-diastole were defined as the times when the 
LV volume reached a minimum and maximum, respectively. Stroke volume was defined 
as the difference between end-diastolic volume and end-systolic volume.  
  
Statistics and Data Analysis  
IFFsystole, IFFdiastole and IFFwhole were compared between the normal controls and 
the patients using an unpaired student’s t-test. A value of p < 0.05 was defined as 
statistically significant. A threshold value of IFF to discriminate between patients and 
controls was defined as the value which gave a maximum sum of sensitivity and 
specificity.  
 
Relationship with Tissue Doppler Dyssynchrony Parameters 
Cross-correlation delays and time-to-peak dyssynchrony parameters were 
quantified in the patients and normal controls as described in Aim 1 (with a stationary, 
30x6 oval region of interest). Each internal flow fraction parameter (whole, systolic and 
diastolic) was plotted against the corresponding cross-correlation delay for each patient 
and normal control. In addition, IFFsystole and IFFwhole were plotted against each of the 
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time-to-peak parameters to determine whether they correlated. 
 
Inter-observer Reproducibility 
To assess inter-observer reproducibility, two independent observers each 
performed complete internal flow analysis including endocardial border detection and 
identification of mitral leaflet insertion points on 5 randomly selected patients and 5 
randomly selected normal controls.  
 
 
Table 6-1: Cardiac function in the patients and normal controls. 
Variable Patients Normal Controls p Value* 
QRS Duration (ms) 193 ± 28 92 ± 10 <0.001 
Volumes    
Left ventricular end-systolic volume (ml) 195 ± 97 48 ± 12 <0.001 
Left ventricular end-diastolic volume (ml) 263 ± 101 128 ± 26 <0.001 
Left ventricular ejection fraction (%) 29 ± 11 63 ± 5 <0.001 




The patients had prolonged QRS durations, increased ventricular volumes, and 
reduced ejection fractions compared to the normal controls (Table 6.1). IFFwhole, IFFsystole 
and IFFdiastole were significantly increased in the patients (p<0.001 versus the normal 
controls for all comparisons) (Figure 6.3). IFFwhole values for each patient and normal 
control are shown in Figure 6.4. An IFFwhole threshold of 4% discriminated between 
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patients and normal controls with 90% sensitivity and 100% specificity (Table 6.2). 
Threshold values of IFFsystole and IFFdiastole to discriminate between patients and controls 









Table 6-2: Discrimination between the patients and normal controls using IFF. 
Variable Threshold* Sensitivity Specificity 
IFFwhole 4% 90% 100% 
IFFsystole 2% 100% 100% 
IFFdiastole 4% 90% 100% 
Values are means ± standard deviation, n = 10 for each group. *Threshold values determined as the level 





Figure 6.4: IFFwhole discriminates patients from normal controls with 95% accuracy. 
 
 
Figure 6.5 shows regional volume curves from a representative patient and a 
normal control. The volume curves are highly uniform in the normal control, representing 
synchronous motion with all segments reaching minimum volume at approximately the 
same time. In contrast, the regional volume curves from the patient are highly non-




Figure 6.5: LV regional volume curves are significantly more dyssynchronous in the 
patients compared to the normal controls. 
 
 
Internal Flow Over the Cardiac Cycle 
Internal flow between the septum and lateral wall of a patient is shown in Figure 
6.6. The regional volume curves from the 5 regions adjacent to the septum (basal and mid 
antero- and infero-septal regions and apical septal region) and the 5 regions adjacent to 
the lateral wall (basal and mid antero- and infero-lateral regions and apical lateral region) 
were summed to simplify the display. Note that internal flow is occurring when the 
volume curves in Figure 6.6 slope in opposite directions (marked by the 2 shaded 
rectangles). In early systole, the volume of blood adjacent to the septum decreases as the 
septum contracts. Simultaneously, the lateral wall volume is increasing. This volume 
change represented by curves moving in opposite directions (shaded rectangle on the left) 
shows internal flow from the early-activated septum towards the lateral wall. In late 
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systole the opposite occurs as the late-activated lateral wall displaces blood volume back 





Figure 6.6: Regional volume analysis shows early and late systolic internal flow in a 
patient that is not present in the normal control. 
 97
 
Systolic and Diastolic Internal Flow 
Figure 6.7 shows the mean internal flow in the patients and controls throughout 
the cardiac cycle. The normal control group had three peaks in internal flow which 
occurred during isovolumic contraction, isovolumic relaxation, and diastolic filling.  
Internal flow in the normals was nearly 3 times greater during diastole (IFFdiastole 
= 2.3 ± 0.8% compared to IFFsystole = 0.8 ± 0.5%, p<0.001). However, this was not the 




Figure 6.7: Internal flow occurs predominately during diastole in normal controls and 





Figure 6.8: XCD correlates weakly with IFF while time-to-peak parameters do not. 
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Relationship with Tissue Doppler Dyssynchrony Parameters 
Correlations between IFF and tissue Doppler dyssynchrony parameters in both the 
patients and normal controls are shown in Figure 6.8. Whole-cycle XCD correlated 
weakly with IFFwhole (p = 0.016). Similarly, diastolic-XCD correlated weakly with 
IFFdiastole (p = 0.047). However, systolic-XCD did not correlate with IFFsystole (p = 0.185). 




The mean inter-observer difference ± 2 standard deviations (in units of internal 
flow fraction i.e. not divided by mean values) was 0.7 ± 1.7% for IFFwhole, 1.2 ± 2.2% for 
IFFsystole and 0.2 ± 2.5% for IFFdiastole. 
 
Discussion 
This study introduces a new method to quantify internal flow due to left 
ventricular dyssynchrony non-invasively using standard cine cardiac magnetic resonance 
images. The major findings are: 1) LV internal flow is 6 times greater in patients with 
dyssynchronous heart failure compared to normal controls, 2) a threshold internal flow 
fraction of 4% discriminates between patients and controls, and 3) internal flow occurs 
predominately during diastole in normal controls while it occurs equally during systole 
and diastole in patients with dyssynchronous heart failure. This is the first study to 
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quantify LV internal flow non-invasively.  
 
Diagnosing Dyssynchrony in Heart Failure 
Ventricular dyssynchrony in heart failure leads to increased morbidity and 
mortality, which can be reduced with cardiac resynchronization therapy (CRT)94. The 
duration of the QRS on surface electrocardiogram is the only clinically accepted measure 
for quantifying dyssynchrony, but it has low sensitivity and specificity for identifying 
patients who will respond to the treatment7, 92. Tissue Doppler imaging has shown 
promise in improving the selection of responders to CRT in small, single-center studies8, 
9, 19, 34, 35. However, the first multicenter trial using tissue Doppler imaging to predict 
response to CRT (the PROSPECT study38) showed that no echocardiographic parameters 
could discriminate responders from non-responders39. Because of this, new parameters to 
quantify dyssynchrony are needed. This study demonstrates that CMR-based 
quantification of internal flow fraction may be a powerful tool in the diagnosis of 
dyssynchrony, and may be useful in selection of responders to CRT. 
Internal flow may represent a more direct measure of cardiac dyssynchrony than 
existing methods used to quantify dyssynchrony. Steendijk et al reported that patients 
with left bundle branch block had an IFFwhole of 78% compared to only 20% in normal 
controls11. This represents a 4-fold difference in patient and normal control values, which 
is similar to the 6-fold difference seen in our study. However, the values from our study 
in both patients and normal controls were smaller than the values reported in the study by 
Steendijk et al in which internal flow was quantified from regional volume measurements 
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made with a conductance catheter. The differences between IFFwhole seen in our study and 
the catheter-based study may be due to the 10-fold higher temporal resolution of the 
conductance catheter or the more complete volume coverage by CMR. CMR-based 
quantification of internal flow has the advantage of being entirely non-invasive, while use 
of a conductance catheter is invasive and expensive. 
 
Internal Flow in Normal Controls 
The normal controls in our study showed three peaks in internal flow during: 1) 
isovolumic contraction, 2) isovolumic relaxation and 3) diastolic filling. The peaks 
during the isovolumic periods are consistent with normal physiology since the ventricle 
undergoes shape changes with no global volume change while the valves are closed. 
Internal flow during the isovolumic periods has also been documented in a previous 
study11. The peak in internal flow during diastole caused IFFdiastole to be 3 times greater 
than IFFsystole in the normal controls. Thus, internal flow is a normal component of 
diastolic filling. Steendijk et al found similar results in patients with coronary artery 
disease and preserved LV function11. 
 
Methodological Considerations 
Nesser et al quantified regional ejection fractions with CMR and showed its 
utility in semi-automated detection of regional wall motion abnormalities95. In that study, 
six long-axis images of the LV rotated in 300 steps were used to reconstruct the 3-
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dimensional endocardial surface of the LV, which results in gaps between the imaging 
planes where the endocardial border cannot be defined. We utilized short-axis images to 
cover the entire LV volume and overcome this limitation. In addition, our methodology 
utilizes CMR images collected during routine CMR protocols whereas collection of 6 
long-axis images is not a standard acquisition protocol. 
The methodology used to quantify internal flow in this study could theoretically 
be applied to 3-dimensional echocardiographic data96. However, a recent study showed 
that 9 out of the 16 standardized regional volumes had significantly different regional 
ejection fractions by 3-dimensional echocardiography in comparison to CMR95. Thus, the 
endocardial border definition from 3-dimensional echocardiography may not be accurate 
enough for internal flow quantification. 
Other CMR-based methods for imaging myocardial motion and evaluating 
dyssynchrony include: 1) tagging methods97-99, 2) displacement imaging methods100, 101, 
and 3) velocity mapping methods102. However, each of these methods requires a 
specialized MR pulse sequence and complex post-processing, which limits their 
widespread use in clinical diagnosis of dyssynchrony. The advantage of IFF methodology 
over these techniques is that it is based on standard cine imaging which is acquired in 
virtually all CMR exams. 
 
Internal Flow versus Tissue Doppler Dyssynchrony Parameters 
We found a weak correlation between IFF and XCD for the whole-cycle and 
diastolic parameters. However, the systolic parameters did not correlate. In particular, 
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one patient had nearly zero internal flow with a high whole-cycle XCD (see top left “x” 
on top left axis in Figure 6.8). This could be explained by an artifact in the images from 
this patient, which made endocardial border definition extremely difficult and potentially 
resulted in an incorrect IFF (Figure 6.9).  
There are several potential explanations for the lack of correlation between 
IFFsystole and systolic XCD. First, valve timings were used to define the systolic phase for 
XCD analysis while volume minima and maxima were used to define the systolic phase 
for IFF analysis. Differences between these timings may have affected the correlation 
between IFFsystole and systolic XCD. In addition, XCD is based entirely on 1-dimensional 
velocity tracings from three different images of the left ventricle, and may be highly 
affected by tethering. However, IFF is based on a stack of at least 10 images used to 
define the precise location of the endocardium at all phases in the cardiac cycle over all 
locations (not just 3 image planes) and probably represents a more complete, accurate 
depiction of myocardial contraction.  
None of the time-to-peak parameters correlated with either IFFwhole or IFFsystole. 
However, Steendijk et al reported a correlation between SLD and IFFwhole in 12 patients 
with heart failure and intraventricular conduction delay (p = 0.002, r = 0.79). Further 





Figure 6.9: An artifact in the images from a patient may have caused inaccurate 




This study has limitations. The methodology used to calculate IFF is time-
consuming, mostly due to the need for accurate LV endocardial border definition. This 
limits the clinical utility of IFF. However, if IFF continues to show clinical value in 
future studies, analysis time could be reduced by focusing on automation of the 
methodology.  
This study is limited by a small sample size. However, the sample size was large 
enough to show statistical differences in IFF between the patients and normal controls. 
Future studies with larger sample sizes will be required to further characterize the utility 
of IFF. 
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Differences in IFF between the patients and normal controls may have been 
confounded by co-factors such as age, heart rate, stroke volume and LV end-systolic 
volume. To investigate this, we employed a backwards selection process starting from a 
complete linear multiple regression model with all potential predictors. Marginally 
insignificant terms were dropped and the model was refit. IFFwhole (p = 0.04) and 
IFFdiastole (p = 0.001) remained significantly different between the patients and control 
groups in the model while IFFsystole (p = 0.096) was confounded by LV end-systolic 
volume. 
We acquired 20 images per cardiac cycle to calculate internal flow. Our 
methodology assumes that the rate of internal flow was constant between phases, which 
may not be true. Increasing the number of images acquired per cardiac cycle can only 
increase the amount of internal flow quantified. Future studies will be needed to 
determine whether more than 20 images per cardiac cycle are needed to accurately 
quantify internal flow. However, we have shown that 20 images per cycle is enough to 




In conclusion, internal flow in the left ventricle can be quantified non-invasively 
from standard cine cardiac magnetic resonance images. An internal flow fraction of 4% 
of stroke volume discriminates between patients with dyssynchronous heart failure and 
normal controls with 95% accuracy. Quantification of left ventricular internal flow from 
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cardiac magnetic resonance images may be useful in identifying patients who will benefit 
from cardiac resynchronization therapy. 
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The overall goal of this project was to develop better methods to diagnose 
dyssynchrony in the left ventricle (LV). We developed and evaluated two new methods 
based on different approaches with different imaging modalities. The first method 
improved upon existing tissue-Doppler based diagnosis of dyssynchrony by utilizing a 
cross-correlation (XC) function to quantify dyssynchrony during post-processing as 
opposed to the quantitatively simplistic “time-to-peak” analysis that is currently utilized. 
The second method utilized standard cine cardiac magnetic resonance (CMR) images to 
quantify the dyssynchrony in the flow of blood within the left ventricle, which may 
represent a more direct, physiologically relevant measure of dyssynchrony.  
The purpose of specific aim 1 was to quantify the effect of region of interest 
tracking on the diagnosis of LV dyssynchrony from tissue Doppler images. Region of 
interest tracking of the myocardium is rarely performed during tissue Doppler post-
processing, but the effect of using a stationary region of interest had never been 
evaluated. The analysis was conducted in 18 patients who satisfied CRT enrollment 
criteria (ejection fraction < 35%, QRS > 120, class III/IV drug-refractory heart failure). 
The XC delay parameters were compared to 3 time-to-peak parameters: septal-to-lateral 
delay in time-to-peak (SLD), maximum difference in the basal 2- or 4-chamber times-to-
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peak (MaxDiff) and standard deviation of the 12 basal and mid-wall times-to-peak (Ts-
SD). This aim demonstrated that XC delays could be accurately quantified with a 
stationary region of interest while the time-to-peak parameters showed poor agreement 
between tracked and stationary analysis. 
The purpose of specific aim 2 was to evaluate the ability of XC delays to diagnose 
dyssynchrony in positive and negative control groups. The analysis was conducted in 11 
positive control subjects (age 68±14) and 12 normal volunteers (age 29±7). Positive 
controls were patients who responded to CRT (greater than a 15% reduction in LV end-
systolic volume 3 months after implantation). The XC delay parameters were again 
compared to SLD, MaxDiff and Ts-SD. All of the XC delay parameters and Ts-SD 
showed significant discrimination between the positive and negative control groups by 
ROC analysis (p<0.01 for all). SLD and MaxDiff did not show significant discrimination 
between the positive and negative control groups (p=0.712 and p=0.056, respectively). 
Threshold values to diagnose dyssynchrony using each XC delay parameter were 
generated from the ROC analysis. A whole-cycle XCD of 25 ms discriminated between 
the positive and negative control groups with 100% sensitivity and specificity. A systolic 
XCD of 53 ms discriminated the groups with a sensitivity of 73% and a specificity of 
75%, while a diastolic XCD of 22 ms discriminated the groups with 91% sensitivity and 
92% specificity. The time-to-peak parameters showed dyssynchrony in a large percentage 
of the negative control group (42%, 50%, and 58%, respectively for SLD, MaxDiff and 
Ts-SD), while the XC delay parameters showed dyssynchrony in 0, 25 and 8% of the 
normal control group, respectively, for whole-cycle, systolic, and diastolic XCD. It was 
concluded that XC delays are superior to existing time-to-peak dyssynchrony parameters 
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at discriminating patients with LV dyssynchrony from subjects with normal function.  
The purpose of specific aim 3 was to evaluate the ability of XC delays to diagnose 
acute “pacing-induced dyssynchrony” in structurally normal pediatric hearts. The 
analysis was conducted in 14 patients (age 13±4 years) undergoing catheter ablation for 
non-preexcited supraventricular tachycardia. Tissue Doppler images were acquired 
during normal sinus rhythm (NSR) and right atrial (AAI) and right ventricular apex 
(RVA) pacing. This enabled evaluation of dyssynchrony parameters in a state of 
dyssynchrony (RVA) compared to normal synchrony (AAI and NSR). XC delay 
parameters were again compared to the time-to-peak parameters SLD, MaxDiff and Ts-
SD. Systolic XCD was the only parameter that showed a significant increase in 
dyssynchrony between RVA pacing compared to AAI (p = 0.031) and NSR (p = 0.005). 
Ts-SD showed a significant difference between RVA and AAI (p = 0.003) but not 
between RVA and NSR (p = 0.095). Threshold values to diagnose dyssynchrony in 
pediatric patients were developed for the time-to-peak parameters and the XC delay 
parameters from the ROC analysis. Systolic XCD had the highest sensitivity and 
specificity (79%) to discriminate between RVA and AAI pacing modes. SLD, MaxDiff 
and Ts-SD had a sensitivity and specificity of 57, 57, and 71%, respectively. Therefore, 
we concluded that systolic XCD was superior to time-to-peak parameters for diagnosing 
dyssynchrony in this model of acute RVA pacing. This data also demonstrated that the 
normal, healthy left ventricle has an inherent ability to preserve diastolic synchrony 
despite a large increase in systolic dyssynchrony during acute RVA pacing. 
The purpose of specific aim 4 was to develop and evaluate a new method for 
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quantifying left ventricular internal flow using standard cine cardiac magnetic resonance 
images. Cardiac magnetic resonance images were obtained from 10 healthy controls and 
10 patients with dyssynchronous heart failure (class III/IV, LV ejection fraction <35%, 
QRS>150ms). A graphical user interface was developed in MatLab which utilized a 
level-set technique to semi-automatically reconstruct the endocardial surface of the LV. 
This surface was divided into 16 regions adjacent to the standardized left ventricular 
segments defined by the American Heart Association. Internal flow was defined as the 
sum of the magnitudes of the regional volume changes minus the global volume change 
during each time step in the cardiac cycle. Internal flow fraction (IFF) was defined as the 
total internal flow as a percentage of stroke volume during systole (IFFsystole), diastole 
(IFFdiastole) or the whole cycle (IFFwhole). IFFwhole was significantly increased in the 
patients (9.9±5.0% vs 1.5±0.5% in the controls, p<0.001). An IFFwhole threshold of 4% 
discriminated between patients and controls with 90% sensitivity and 100% specificity. 
IFFdiastole (2.3±0.8%) was greater than IFFsystole (0.8±0.5%) in the normal controls 
(p<0.001) while the patients had similar IFFdiastole (7.8±4.2%) and IFFsystole (12.0±7.8%). 
It was concluded that left ventricular internal flow fraction can be quantified from 
standard cine cardiac magnetic resonance images. Left ventricular internal flow fraction 
discriminated patients with dyssynchronous heart failure from normal subjects with 95% 
accuracy. 
To facilitate comparisons between XCD and IFF, XCD was quantified in all 
patients and normal controls from Aim 4. We found a weak correlation between IFF and 
XCD for the whole-cycle and diastolic parameters (p = 0.016 and 0.047, respectively). 
However, the systolic parameters did not correlate (p = 0.185). In addition, none of the 
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time-to-peak parameters correlated with either IFFwhole or IFFsystole. This suggests that 
while IFF and XCD may correlate weakly, they are not in close agreement and may 
provide independently useful information. 
 
Clinical Implications 
The overall goal of this project was to improve upon existing methods to diagnose 
dyssynchrony in the heart. This goal is particularly important as the existing methods to 
diagnose dyssynchrony have recently failed in the first multi-center trial attempting to 
predict response to CRT (PROSPECT). The work presented in this dissertation provides 
a new method (cross-correlation delay) for post-processing of tissue Doppler velocity 
curves that can be used to diagnose left ventricular dyssynchrony in a more automated, 
streamlined fashion with greater accuracy than existing “time-to-peak” parameters. This 
work also provides a new method for quantifying left ventricular internal flow non-
invasively as a new measure of dyssynchrony. Internal flow analysis showed excellent 
accuracy in discriminating positive and negative control groups in a preliminary study. 
Both tissue Doppler-based cross-correlation delay and cardiac magnetic resonance-based 
internal flow analysis may help improve the poor CRT response rate. In addition, the 
superior ability of these methods to diagnose dyssynchrony may prove useful in risk-
stratification and monitoring of other disease processes which affect the heart. 
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Suggestions for Future Work 
Predicting Response to CRT using XCD 
The next step in determining the utility of XCD for diagnosing dyssynchrony is to 
determine whether these parameters can predict which patients will benefit from cardiac 
resynchronization therapy (CRT). The predictors of response to CRT (PROSPECT) trial 
aimed to identify echocardiographic measures of dyssynchrony and evaluate their ability 
to predict response to CRT38. SLD, MaxDiff and Ts-SD were 3 of the parameters 
quantified in the patients at baseline prior to biventricular pacemaker implantation. 
PROSPECT enrolled 460 patients from over 30 centers world-wide and utilized two core 
labs to analyze all echocardiographic data. However, the preliminary results showed poor 
reproducibility of the echocardiographic parameters between core labs and non-
significant predictive ability of all parameters studied39. The results of this dissertation 
suggest that cross-correlation delay should be evaluated in the PROSPECT study 
population to determine whether XCD can be used to predict response to CRT.  
 
Correlation Value 
Cross-correlation analysis produces two numerical values when comparing two 
velocity curves: 1) the delay between the curves and 2) the normalized correlation value 
after correcting for the delay between the curves. Correlation values less than ~0.5 may 
not be reliable (see Figure 4.8 for an example). Future studies determining the ability of 
XCD to predict response to CRT should analyze patients with correlation values above 
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0.5 and below 0.5 as separate groups to determine whether the predictive ability is limited 
for low correlation values. 
 
Pacing-induced Diastolic Dyssynchrony 
Chapter 5 demonstrated that dyssynchronous activation of the left ventricle due to 
right ventricular apex pacing creates systolic dyssynchrony with preserved diastolic 
synchrony. However, chapter 4 showed that patients with heart failure have a severely 
increased level of diastolic dyssynchrony compared to normal controls. Thus, diastolic 
dyssynchrony is not an acute effect of dyssynchronous activation and may be a long-term 
marker of worsening function due to pathology of the myocardium. It will be important 
to investigate whether patients who have had right ventricular pacemakers for prolonged 
periods of time have developed diastolic dyssynchrony. 
 
Predicting Response to CRT using IFF analysis 
Calculation of IFF involves significantly more post-processing and complicated 
analysis compared to XCD. However, its utility may lie in the fact that it is a more 
physiologically relevant measure of “inefficiency” in the left ventricle that can be 
corrected by cardiac resynchronization therapy. IFF analysis is more related to the actual 
increase in efficiency that CRT can provide for a patient. A trial determining the ability 
of IFF to predict response to CRT is definitely warranted based on the data presented in 
chapter 6. In addition, several centers have successfully obtained magnetic resonance 
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images from patients with pacemakers103, 104. This suggests that the primary end-point of 
change in LV end-systolic volume for a CRT study using IFF analysis could be 
quantified with MRI as opposed to echo, which would improve the power of the study 
nearly 10-fold due to the much higher reproducibility of calculating volumes with MRI 
instead of echocardiography105. 
 
Fusion of Multiple Modalities to Predict Response to CRT 
There are several other factors that affect outcomes after CRT which can be 
addressed with cardiac MRI. Patients with increased scar burden have a reduced chance 
of responding to CRT106, 107. MRI delayed enhancement imaging is the gold standard for 
quantifying the extent and severity of myocardial scar burden, and has been used to 
predict response to CRT108. In addition, it can be difficult to access veins for placement 
of the left ventricular lead in the region of optimal pacing in many patients109. Techniques 
have recently been developed to visualize the coronary venous anatomy with MRI110. 
Figure 7.1 shows four slices from a 3-D, post-contrast, navigator echo-gated, whole-
heart, coronary vein scan. The arrows show sections of the coronary veins in each slice 
that can be used to reconstruct the veins in 3 dimensions. Therefore, cardiac magnetic 
resonance can be used to quantify: 1) dyssynchrony using IFF analysis, 2) viability using 
delayed enhancement imaging and 3) coronary venous anatomy. These 3 modalities can 
be acquired during the same cardiac exam and could be combined in the future to provide 
a more complete description of a patient’s chance of benefitting from CRT. 
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Figure 7.2: An implementation of the geometric heat equation for smoothing cardiac 




Improvement of the Post-processing Time for IFF 
Calculation of IFF can require up to 6 hours to complete for one patient, mostly 
due to manual correction of the endocardial border identified using a level set method. 
Post-processing time may be reduced by implementing: 1) non-linear edge-preserving 
smoothing algorithms based on the geometric heat equation prior to segmentation (Figure 
7.2) 2) three or four-dimensional (three spatial plus one time dimension) evolution of the 
level set instead of two-dimensional evolution in each image and/or 3) time evolution of 
the endocardial border from the first cardiac frame using optical flow (Figure 7.3). In 
addition, quantification of IFF may not be very sensitive to manual refinement of the 




Figure 7.3 Optical flow-based propagation of the endocardial border in time using the 
first (top left) frame as an initial condition. Predicted borders are in green and 
manually-identified borders are in red. 
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Pronunciation of ChipoTle 
Despite eating at the restaurant Chipotle nearly 20-30 times with John Oshinski 
throughout my graduate career, he still has yet to learn how to annunciate the word. No 
matter how many times we tell him that the proper phonetic spelling is “chi-poht-ley,” he 
continues to pronounce it “chi-polllllll-teeeeeee” for reasons unknown. Potential methods 
for improving upon this situation are: 1) Send John to Catholic school with his kids to 
take speech therapy classes 2) make John take a shot of the Chipotle fire salsa every time 
he pronounces it incorrectly and 3) stop going to Chipotle and go to Moe’s because it’s 
easier to pronounce. However, in all of those 20-30 visits to Chipotle, I must admit I may 
have paid for myself a maximum of two times. If this incredible streak of free meals 
continues, I am fully willing to deal with John’s speech problems without hesitation. 
 
Final Thoughts 
There are a multitude of methods to quantify ventricular dyssynchrony. The 
majority of these methods were developed within the clinical realm to predict outcomes 
after cardiac resynchronization therapy. Therefore, these methods never underwent 
rigorous scientific evaluation in positive and negative control studies. We developed two 
new methods to quantify dyssynchrony and showed their superiority to existing 
techniques in positive and negative control studies. We feel these methods will be useful 
in diagnosing dyssynchrony in the setting of severe, drug-refractory heart failure to help 
improve selection of patients who will benefit from cardiac resynchronization therapy. In 
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addition, it is becoming apparent that dyssynchrony may lead to worse outcomes in other 
populations such as children who require a pacemaker for heart rate control80, and our 
methodology should be directly applicable to this and any other cardiovascular disease 
affecting the normal activation pattern in the heart. 
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